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The Tier 1 Select Agent, Francisella tularensis causes an acute and fatal disease known as 
tularemia. Many studies have devoted enormous efforts to understand how F. tularensis avoids 
host defense mechanisms, replicates within an extremely secure immune system, and 
eventually causes the deadly disease tularemia. The extremely high virulence of Francisella 
depends on its ability to manipulate gene expression according to the surrounding environment. 
This process requires the involvement of unique transcriptional regulators. Francisella possesses 
very few transcriptional regulators, and a majority of them characterized to-date have been shown 
to regulate genes involved in virulence and cellular functions. The role of a transcriptional regulator 
of F. tularensis belonging to the AraC/XylS in gene regulation and virulence remains 
uncharacterized to-date.  This study characterized the role of AraC in gene regulation, 
intramacrophage survival, and virulence of F. tularensis. 
  
In specific aim 1, we generated a deletion mutant (araC) of FTL_0689 gene encoding AraC of F. 
tularensis Live Vaccine Strain (LVS), and its transcomplemented strain (araC+paraC). 
Characterization of the araC mutant demonstrated that AraC does not regulate genes involved 
in arabinose utilization. Genomic organization of the araC gene suggested that it may have a role 
in the regulation of a unique multidrug efflux pump (MEP) located downstream of it. Our results 
revealed that the phenotype of the araC mutant mirrors that of the emrA1 and the silC mutants, 
the components of the MEP. However, these phenotypic similarities are not due to the direct 
regulation of MEP genes by AraC. Further characterization revealed that AraC is involved in 
providing resistance against oxidative stress.  
xvi 
 
In specific aim 2, we investigated the role of AraC as a global transcriptional regulator in F. 
tularensis LVS strain. We studied gene expression profiles of the wild type F. tularensis LVS 
and the araC mutant under normal and oxidative stress conditions. The results revealed that AraC 
serves as a transcriptional regulator only when the bacteria are exposed to oxidative stress 
conditions. AraC is involved in the regulation of virulence genes encoded on Francisella 
Pathogenicity Island, stress response genes, energy production, genes encoding enzymes in the 
tricarboxylic acid (TCA) cycle, metabolism and regulatory proteins indicating its role as a global 
regulator. The differential expression of these genes also impaired the ability of the araC mutant 
to survive in macrophages and attenuated its virulence in mice.  
 
Collectively, this study identified and characterized a novel transcription factor, AraC, required for 














1.1. Francisella tularensis 
 F. tularensis is a Gram-negative bacterium that is extremely infectious and as few as ten 
bacteria can cause a deadly zoonotic disease [1, 2]. In 1912, F. tularensis was first discovered 
in Tulare County, California as the causative agent of a disease in ground squirrels that 
resembled plague [3]. After that, Edward Frances greatly devoted his efforts to studying this 
bacterium and discovered that it causes a disease with different clinical manifestations in 
human and named that disease “tularemia” [4]. Francisella genus was then named after him 
as a reward, and the species tularensis was derived from the Tulare County [5]  Francisella 
descends from the gamma-subclass of the phylum proteobacteria as classified according to 
small subunit RNA sequencing and is the only genus within the Francisellaceae family [6]. 
The Francisella genus branches out into two species: tularensis and philomiragia, which were 
categorized based on their fatty acid and genetic material identity [6, 7]. F. tularensis has been 
subdivided into four major subspecies: F. tularensis subsp. tularensis (Type A or also referred 
to as Schu S4) and F. tularensis subsp. holarctica (Type B), which are virulent for humans 
while the other two subsp., F. tularensis subsp. novicida (referred to in this study as F. 
novicida) and F. mediasiatica are known to be avirulent [8]. One more subspecies of F. 
tularensis isolated in Japan has been identified and is an F. tularensis subsp. holarctica variant 
[9] (Figure 1). Furthermore, molecular studies including Multiple-Locus Variable-number 
Tandem Repeat (VNTR) Analysis subdivided Type A strains into two genetically unrelated 
clades known as type A1 and type A2 [10, 11], Type B strain into: B1, B2, B3, B4, and B5 
[11], and currently, F. tularensis subsp. mediasiatica was also subdivided into three clades: 
M1, M2, and M3 [12]. 
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 The geographic distribution of F. tularensis differs between Type A and Type B strains 
[13]. While Type B is less common in North America and prevalent throughout Europe and 
Asia, Type A is confined to North America and was also isolated from Central Europe [11, 
13]. In addition, the avirulent strains F. novicida and mediasiatica were isolated in the Great 
Salt Lake, Utah from Ogden Bay salt water in 1950 [3] and Central Asia, respectively [14]. 

















1.1.1. Disease transmission 
 Type A and Type B strains of F. tularensis are highly contagious. They can be acquired 
through insect bites, direct contact with diseased animals, ingestion of contaminated food or 
water, or by inhaling bioaerosols [3]. A majority of F. tularensis infection around the world is 
caused by Type B strains [15, 16]. The high mortality rate in North America as a result of F. 
tularensis infection is related to Type A strains, whereas Type B strains are less severe for the 
disease across the Northern Hemisphere. This indicates that the natural distribution of Type A 
and Type B in addition to the severity of the disease is distinct between the two subspecies of 
F. tularensis. However, there is no record of F. tularensis subsp. mediasiatica infection in 
humans [3]. In contrast, F. novicida can infrequently cause illness in immunocompromised 
humans but is highly lethal for rodents [17]. In addition, preliminary investigations indicate 
that the bacterial morphology of this subspecies resembles the pathogenic F. tularensis strain 
as they share about 78% to 97% of the genetic material [7]. Nevertheless, it is less virulent, 
metabolizes sucrose, and does not show any immunologic reaction when administered into F. 
tularensis immunized rabbits [18]. This suggests that F. novicida is an excellent tool for 
Francisella and tularemia research [17]. 
 
1.1.2. Clinical signs and symptoms 
 The onset of tularemia is very fast causing flu-like symptoms such as high temperature, 
sore throat, headache, chills, and general bodily weakness or discomfort [19]. The severity of 
the disease depends on various factors including the route of administration, bacterial dosage, 
and infecting Francisella subspecies [20]. Moreover, different portals of entry can show the 
different clinical manifestation of tularemia in humans [21, 22]. For instance, direct contact 
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with infected animals or transmission through insect bites can ulcerate the target area and result 
in glandular and ulceroglandular tularemia, which is the most frequent form of the disease. 
This will lead to systemic infection due to bacterial drainage to the nearest lymph node [23]. 
There is also oculoglandular and oropharyngeal tularemia that are caused by eye infection or 
ingestion of contaminated materials, respectively. The most acute form of the disease in 
humans is pneumonic tularemia which is induced by bacterial inhalation but fortunately, this 
occurs infrequently under natural conditions [23, 24].  
 
1.1.3. Bioweapon potential 
 The concern of using F. tularensis as a potential bioterrorism weapon has emphasized 
the importance of classifying it as a Tier 1 Select Agent by the U. S. CDC. The reason is that 
F. tularensis has low infectious dosage, ease of transmission, and the ability to cause high rates 
of morbidity and mortality [24]. Presently, vaccines against tularemia are not available [25]. 
In spite of the development of LVS from a Type B strain in the former Soviet Union, it is not 
approved for human immunization in the United States because it is not safe or effective 
against respiratory tularemia caused by Type A strains of F. tularensis [25, 26]. The Russian 
vaccine strain was used to derive the LVS by several passages on peptone cysteine agar [25]. 
Although LVS is not used to vaccinate humans, it is being used in research studies for several 
reasons. One is that the LVS is safe to handle in biosafety level 2 laboratories. Secondly, it has 
both high virulence in mice and the ability to replicate identically to the virulent strains. In 
addition to that, the virulence genes in Type A and Type B strains are found to be conserved 
in the LVS, which favored using LVS to a large extent in the majority of F. tularensis studies 
[27, 28].   
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1.2. Intracellular life cycle of F. tularensis 
F. tularensis is a non-obligatory intracellular bacterium which can infect different cells 
including phagocytes such as monocyte-derived macrophages (MDMs) or polymorphonuclear 
leukocytes (PMN) and non-phagocytes such as respiratory epithelium and fibroblasts [28-30]. 
While macrophages are one of the primary and crucial cells that interact with F. tularensis [23] 
and are the focus of most studies, the other cell types that bacteria prefer for infection are due 
to unknown reasons [28-30]. The life cycle of F. tularensis, upon its entry into macrophages, 
is very distinctive since it prevents phagosome maturation and escapes into the cytosol for 
replication [24, 30] (Figure 2).  
The innate immune response initially comes into play and activates defense 
mechanisms including complement system, antibodies, and host defense peptides (HDPs) once 
F. tularensis infection is established [23]. If the bacteria fail to resist any of these mechanisms, 
they will be defeated, and the infection will be cleared [31]. However, this is not the case with 
F. tularensis. It utilizes several structural adjustments to overcome the innate immune response 
and avoid any bacteriolysis that allows immune recognition due to the induction of the 
proinflammatory cytokines and, then, activates a robust adaptive immunity [23] (Figure 3).   
Phagocytes engulf F. tularensis rapidly, within about an hour of infection [29], by 
receptor-mediated phagocytosis and enclose it in a phagosomal compartment containing 
antimicrobial compounds required for bacterial degradation [23]. These antimicrobials 
generated by the phagocytic cells are as a result of a multi-component assembly of a 
membrane-attached enzymatic complex, known as nicotinamide-adenine dinucleotide 
phosphate (NADPH) oxidase responsible for turning molecular oxygen into negatively 
charged and highly toxic superoxide radicals [32]. Thus, at the time of phagocytosis, NADPH 
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oxidase subunits aggregate in the phagosomal vacuole to assemble and produce reactive 
oxygen species (ROS) [23], which, however, F. tularensis can resist extremely efficiently [33]. 
Accordingly, Francisella fights these microbicidal mechanisms by some unique 
mechanisms and by the escape into the cytosol [23]. F. tularensis phagocytosis not only 
supports bypassing extracellular immune defense factors [23] but also avoids the stimulation 
of pro-inflammatory cytokines [29]. In addition, F. tularensis suppresses immune recognition 
by stimulating transforming growth factor β (TGF-β), prostaglandin E2, or production of other 
anti-inflammatory cytokines via undiscovered mechanisms [29]. When Francisella is in the 
cytosol, it undergoes rapid replication in spite of the presence of various immune defense 







Figure 2.  Intracellular life cycle of F. tularensis. Francisella is internalized by various-
receptors mediated phagocytosis into a phagosome known as Francisella Containing 
Phagosome (FCP). Francisella must evade antimicrobial molecules such as NADPH 
oxidase that produce ROS and cause respiratory burst. Francisella then disrupts the 
phagosome and escapes into the cytosol to undergo several rounds of multiplications 
resulting in host cell death. This will be followed by bacterial release to infect new cells. 














Figure 3. Stimulation of extreme immune response upon failure to defeat F. tularensis 
infection. Inhalation of bioaerosoles containing F. tularensis results in bacterial entry into 
the lamina propria lining of the lung where antigen presenting cells ingest bacteria and 
transfer them into the regional lymph nodes. The bacteria will then be presented to T-cells 
that will proliferate and produce Interferon-gamma (IFN-γ) and activate macrophages. If the 
immune system fails to clear the bacteria, cytokine storm will be produced and bacterial 
infection will end in granuloma formation. Modifed from Murray P. R., 2009 [34]. 
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1.3. Immunity to Francisella 
  After Francisella infection was established, anti-Francisella antibodies and other 
immunogenic molecules are produced in the host against the bacterial antigen, 
lipopolysaccharides (LPS) [35]. Vaccination with LVS also induced the production of potent 
serum antibodies: IgM, IgA, and IgG within two weeks and was found to specifically target F. 
tularensis LPS [36]. The multispecific IgM antibodies mostly induce the early protection 
against F. tularensis LVS infection through the intradermal and intranasal routes [37]. 
Furthermore, the mucosal IgA was found to be involved in the protection against F. tularensis 
LVS as it was isolated from the infected host sera and bronchoalveolar lavage (BAL) [38, 39]. 
Another indication of the IgA involvement is that vaccination through the intradermal route 
did not protect against LVS intranasal challenge whereas using the intranasal route for 
vaccination protected against other routes of administration [35, 40, 41]. Unfortunately, human 
vaccination with LVS did not produce enough anti-Francisella antibodies that protect against 
the virulent Francisella strain. However, vaccination with killed Francisella successfully 
induced the production of anti-Francisella antibodies but stimulated weak or no cellular 
immunity [36, 42]. 
  Interestingly, using LVS, Schu S4, or monophosphoryl lipid A (MPL) component of 
LPS to perform nanoparticles incorporating lysate provides immunity against the LVS 
challenge in mice [37]. Not only does the nanoparticles incorporating lysate produce serum 
antibodies, but it also stimulates and expands the production of T-cell dependent cytokines 
[35]. Francisella, as an intracellular pathogen, avoids detection by antibodies unless 
translocated to the extracellular environment where antibodies take place and thus, support the 
induction of T-cells response [35]. Consequently, T-cells proliferate and stimulate the 
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production of T helper 1 (Th1)-type cytokines particularly the INF-γ [36]. INF-γ is an 
important cytokine for T-cells priming to LVS as injecting mice intraperitoneally (IP) with 
anti-INF-γ antibodies results in a very high morbidity rate unless the mice were challenged 
with the lowest dose of LVS [43]. Furthermore, in vitro stimulation of immunity using T-cells 
isolated from mice with INF-γ deficiency does not successfully prevent LVS intramacrophage 
replication [43]. Proliferated T-cells also induce the production of tumor necrosis factor-alpha 
(TNF-α), which activates responding memory T-cells [44]. 
  The establishment of robust memory T-cells is an essential factor in the protection 
against intracellular organisms [45]. After T-cells recognize the antigen presented on the 
surface of antigen presenting cells, they proliferate and differentiate into memory T-cells. The 
peripheral blood mononuclear cell (PBMCs) post-LVS vaccination contained memory CD4+ 
and CD8+ T-cells that induce the production of cytokines IL-17 and IL-22, which are produced 
by T helper 17 (Th17) cells, a subset of memory T-cells [46]. The level of pulmonary IL-17 is 
very crucial for successful vaccination against the virulent strain Schu S4 [47]. Depleting IL-
17 with neutralizing antibodies at the time of the secondary challenging has been observed to 
increase the bacterial burden in mice lungs [47]. Furthermore, CD4+ and CD8+ T-cell 
responders of PBMCs of tularemia patients or after vaccination with LVS exhibited a 
phenotype of effector memory T-cells that have the ability to induce cell lysis, target variety 
of tissues, and persist in the host sera for up to 25 years after the first establishment of 
pneumonic tularemia [36, 45]. Moreover, B-cells were found to contribute to the secondary 
infection to F. tularensis as they function similarly to antigen presenting cells as well as 




1.4. Virulence factors 
 F. tularensis is a firm, long-living organism that has the ability to tolerate low temperatures 
and to exist for several weeks in different conditions including wet soil, dried grass, and even 
on decomposed dead animals [24]. Francisella is also a non-spore-forming bacteria enveloped 
by a thin layer of lipopolysaccharide [24]. At present, the virulence factors of F. tularensis and 
the mechanisms that it uses to subvert host’s immune response are not clear [2]. Studies have 
shown that although LVS is attenuated for virulence in humans, it still causes extreme illness 
in animals and results fatal disease in rodents similar to human infection [26]. LVS can 
certainly adjust to intra-phagosomal life [49, 50] in mice macrophages and subsequently cause 
structural damages to them [2]. Managing virulence mechanisms in Francisella is not 
controlled by a specific protein or system. It is a concurrent activity of various systems that 
help Francisella to abolish immune defenses, enter host cells, subvert phagosome 
antimicrobials by modifying phagolysosome maturation, escape to the cytosol and replicate 
with host recognition avoidance, manipulate cell survival/death, and spread to neighboring 
cells for new infection [19]. Some of the currently studied virulence factors are located within 
Francisella’s envelope which are comprised of the capsule, LPS, outer and inner membranes 
(OM / IM), periplasm, and bacterial secretion systems [19]. 
 
1.4.1. Francisella capsule 
The production of the capsule by F. tularensis is completely sustained in most of the 
biovars [51]. It mostly consists of lipids, around 51%, and the remaining is amino acids and 
carbohydrates (35 % and 21% respectively) [52]. The density of the capsule is about 0.02 – 
0.04 μm and it is translucent according to Hood et al., who revealed that it has a virulent 
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function in F. tularensis [52]. Further studies demonstrated that the capsular materials 
composed of polysaccharides that were similar to one of the LPS component (O-antigen) [51] 
solely, but no other parts of the LPS, such as 2-keto-3-deoxyoctulsonicacid (KDO) and lipid 
A, were found by the mass spectrometry and nuclear magnetic resonance (NMR) analysis [51, 
53]. Additionally, the sugar composition of the capsule was found to be distinct among F. 
tularensis strains such as Schu S4, whose capsule contains two sugars: mannose and rhamnose; 
whereas LVS capsule has three: mannose, glucose, and galactose [53]. Some studies have also 
shown that different strains produce various capsular-like molecules either due to the bacterial 
growth conditions or the surrounding environment, which could be significant to the virulence 
pathway [19]. In addition, LVS capsule production was higher when the bacteria were grown 
on Chamberlain’s medium and resulted in a more aggressive bacterial infection in mice upon 
intravenous inoculation [54]. 
In contrast to virulent F. tularensis strains, Schu S4, and LVS, F. novicida neither 
produces capsule nor its O-antigen [55, 56]. However, studies have found that F. novicida 
posses a locus that is highly identical to that responsible for capsule-like complex (CLC) 
glycosylation of F. tularensis [55]. This CLC is an extracellular component that is produced 
by F. tularensis during certain growth conditions [53]. This may imply that CLC is a potential 
virulence factor of F. novicida [55].  
Capsule formation in F. tularensis substantially contributes to F. tularensis evasion of 
any intracellular immune responses and in general, any in vivo or in vitro virulence 
mechanisms [19]. It can protect Francisella from being opsonized either by complement or 
antibodies; however, it is not yet understood if it is essential for serum resistance or contributes 
to this mechanism in association with other factors [19]. There were many attempts to design 
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the F. tularensis vaccine that targets capsule because of their surface localization [19]. 
Nevertheless, conflicting results have been observed when  Schu S4 or the LVS capsular 
proteins are used for intraperitoneal immunization, as Schu S4 did not show any protection in 
guinea pigs or in mice [52]. On the contrary, LVS capsular proteins protect mice only against 




Another virulence factor that F. tularensis employs for immune evasion is LPS. It 
consists of lipid A, the O-antigen, and the middle domain which is made of oligosaccharide 
[57]. F. tularensis lipid A differs from the Escherichia coli (E. coli) lipid A in that it is 
tetraacylated and has 16-18 extent of carbon [58, 59]; while the latter is hexaacylated with 12-
14 stretch of carbons [19]. Lipid A can trigger the immune system as most Gram-negative 
bacteria can modify it for virulence mechanisms [60]. The polysaccharide repeats of the O-
antigen; however, are conserved among the virulent strain Schu S4 and the LVS; but differ 
from those of F. novicida as detected by mass spectrometry and NMR analysis [61-64] (Figure 
4).  
Studies have demonstrated that LPS-targeted vaccines show protection only against 
homologous challenge with the same species [65]. For instance, using F. novicida lpxF strain 
for immunization protected mice only from wild type F. novicida challenge, but not from 
challenge with Schu S4 or subsp. holarctica strains [65]. Interestingly, 60-95% of Francisella 
lipid A, unlike that of other Gram-negative bacteria, was found to be missing the core or the 
O-antigen domains, and these are known as free lipid A [66-68]. In addition, Francisella can 
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control the length of the acyl chains according to the surrounding temperature, and this is an 
essential virulence mechanism since infecting mice subcutaneously with F. novicida lpxD1 
mutant (LPXD1 is an enzyme that adds carbons to acyl chains) was not virulent [69]. These 
LPS alterations are significant for Francisella to lower the chances to be recognized by one of 
the host LPS detectors, such as LPS-binding proteins, Lymphocyte antigen 96 (MD-2), or Toll-
Like Receptor 4 (TLR4) [70-72]. 
 Normally, Francisella LPS is insufficient to stimulate B-cells. However, at an extreme 
high dose, such as 75 μg, F. novicida LPS can promote murine white blood cells to proliferate 
[19]. E. coli LPS, on the other hand, enhances B-cell activation via LPS recognition proteins 
[19]. Although Francisella alters LPS and avoids innate immune system detection, the 
classical pathway of the complement system is induced by some strains such as LVS [73]. The 
C3b subunit of the classical pathway opsonizes F. tularensis and facilitates its internalization 
into host cells. However, the bacteria have to avert the genesis of the membrane attack complex 
by the complement components [19]. Studies revealed that Schu S4, LVS, and F. novicida are 
resistant to complement activation because this process depends on the O-antigen subunit of 
LPS [74]. Thus, the studies above suggest that F. tularensis controls the phagocytosis process 
due to the presence of the O-antigen subunit in any of the capsule or LPS [19]. Furthermore, 
TLR4 was found to be deactivated to a great extent because of LPS alteration and subsequently, 
it resulted both in evading the immune system and enhancing the virulence mechanism in 
general [19]. Taken together, Francisella depends on the O-antigen, either in LPS or capsule 
together with the plasmin, to evade the host’s first line of defense, the complement system. 
This, in turn, avoids a robust immune response that would normally be induced via pro-
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inflammatory release when bacteria are detected and ultimately killed by pathogen-associated 





Figure 4. O-antigen of F. tularensis versus F. novicida: The O-antigen repeating molecule 




1.4.3.  Type IV pili 
 Most of the Gram-negative organisms possess Type IV pili which act as an essential 
virulence factor as it helps in the attachment to the host cell, gives the bacteria a special 
movement technique known as twitching motility, helps bacterial assembly and DNA 
acquisition [75, 76]. In F. tularensis, studies have demonstrated that growth conditions can 
modify the shape of Type IV pili; for instance, culturing LVS on agar produces horn-like Type 
IV pili while growing LVS on broth produces elongated cylindrical fiber-like Type IV pili 
[77]. The Type IV pili are observed on F. tularensis Schu S4 and F. novicida [78, 79]. Some 
studies, on the other hand, reported that no pili are detected neither on subsp. holarctica strain 
nor F. novicida, suggesting that the presence of pili depends either on Francisella strain or on 
growth conditions among different laboratories [80, 81].  
The pilus is composed of five or six pilin subunits; from PilE1 to PilE6 [77, 79]. 
Genomic sequencing of F. tularensis indicated that Schu S4 and F. novicida have the six 
subunits while Type B strain has many mutations or deletions in pilE1, pilE2, or pilE3 [79]. 
LVS, on the other hand, has pilE1 deleted and pilE2 and pilE3 containing premature stop 
codons [77]. In particular, PilE1 was found to be playing an important role in Francisella 
virulence. During infection, LVS forms several glycosylated multimers of PilE1 on its surface. 
It is this glycosylation of Type IV pili that makes it infectious [80]. Previous reports on mice 
subcutaneously infected with either Schu S4 or Type B strain was also found to have the 
virulence factor PilE1 and was determined to be responsible for the entire virulence 
mechanisms of these strains [80, 82]. Furthermore, Salomonsson et al., reported that trans-
complementation of pilE1, along with or without other genes in LVS, makes the bacteria highly 
virulent [83]. Studies also noted that the proteins which are important for Type IV pili assembly 
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in Francisella play an important role in the virulence [19]. Thus, like other Gram-negative 
bacteria, Francisella expresses Type IV pili that enhance bacterial virulence and intracellular 
survival.  
 
1.4.4. Francisella secretion systems 
 Most Gram-negative bacteria have Type I secretion system that facilitates toxins and 
drugs transport and thereby assists in the virulence mechanisms [84-86]. Three ortholog genes 
of the outer membrane, tolC, of E. coli and other bacteria were detected in F. tularensis by the 
genomic and bioinformatic analysis. These genes are tolC, ftlC, and silC with the locus tags 
FTL_1865, FTL_1107, and FTL_0686, respectively [87], and are found to be essential for LVS 
resistance to antimicrobial drugs, dyes, and detergents [87, 88]. The structure of Type I 
secretion system is characterized by the association between three subunits: the OM TolC, an 
IM ATPase, and a transmembrane protein, forming a three-component system [89]. In a study 
using Schu S4 tolC mutants, it was found that they were partially attenuated following 
intradermal mice infection as mice survived two more days as compared with those which 
received wild type bacteria [90]. LVS tolC mutants were unable to survive and therefore could 
not spread within the host cells, leading to conditions which were permissive for the pro-
inflammatory cytokines cascade, which in combination, led to macrophage death. This 
suggests that TolC might be contributing to other unknown virulence pathways [91, 92]. 
Another protein on F. tularensis OM, SilC, identical to silver cation efflux proteins, has some 
sequence similarity with TolC and FtlC [93]. A study conducted from our lab has characterized 
the role of SilC in F.tualrensis LVS and demonstrated that this OM protein is involved in the 
resistance to antibiotics, oxidants, and silver. In addition, SilC is also crucial for F. tularensis 
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virulence in vivo and in vitro [87]. Another study on OM orthologs of Schu S4 showed that 
TolC was required for in vivo virulence when bacteria were administered intranasally and 
intradermally. However, FtlC was required for virulence using the intradermal route of 
administration, indicating that F. tularensis virulence is dependent on the route of entry to the 
host [94].   
  Gram-negative bacteria also have Type III and Type IV secretion systems that are 
essential for the bacterial virulence mechanism and are characterized by infusing effector 
proteins through the plasma or internal membranes [95-97]. F. tularensis, especially Schu S4, 
lacks any of Type III or Type IV secretion system orthologs or functional proteins [98]. 
Although studies have identified some of the virulent genes that share homology with Type III 
and Type IV secretion systems in F. tularensis subsp. mediasiatica, these genes are determined 
to be non-functional in Francisella species.  To date, no intact or functional Type III or Type 
IV secretion systems have been detected in Francisella except Type IV pili biogenesis system 
that has some subunits shared with Type III secretion system while the majority of other 
subunits are homologous to components of Type II secretion system [88, 99, 100].  
 Additionally, studies on F. novicida indicated that Francisella pathogenicity island 
(FPI) encodes Type VI secretion system [101, 102], which is described by infusing the effector 
proteins into host cells or other bacterial cells in a similar manner to the T4 bacteriophage 
injecting mechanism [103, 104]. Two proteins, IglA and IglB, compose the outer sheath of 
Type VI secretion system and are found to be arranged together when the bacteria are under 
stress, such as during phagocytosis, an alkaline environment (5% KCl), and oxygen availability 
[105], suggesting that Type VI secretion system might be important for Francisella virulence. 
Other important subunits, such as DotU and VgrG, also promote phagocytosis resistance and 
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virulence during intradermal or intranasal mice infection [101, 106]. Moreover, LVS uses Type 
VI secretion system to secrete IglC, IglE, IglF, IglI, IglJ, PdpA, PdpE, and VgrG effector 
proteins into host macrophages, while IglC, IglE, PdpA, and PdpE proteins are secreted by F. 
novicida, suggesting that every species has its specific Type VI secretion effector proteins 
[107]. Type VI secretion system effector proteins are not fully characterized despite the 
involvement of this secretion system in the virulence of F. novicida in a mouse model [7]. 
 
1.5. The Multidrug efflux pump (MEP) system 
 F. tularensis have evolved other mechanisms to avoid or counter the host immune 
system [23]. These mechanisms depend on the nature of the host defenses that the bacteria 
encounter. For example, when F. tularensis confront host defense peptides, it can repulse the 
interaction between them and avoid their antimicrobial effect by managing its surface charge 
as these peptides are usually positively charged [23]. However, some antimicrobial peptides 
have no surface charge or can bear the same charge as the bacteria, which makes it difficult for 
F. tularensis to resist them by modifying its surface charge. Thus, F. tularensis uses another 
strategy that employs the MEP system to help diffusing antimicrobial drugs out of the 
bacterium [23].  
  F. tularensis subverts host defensins and other microbicidal components by encoding 
one or more of the MEPs similar to other bacteria including Neisseria, [108], Pseudomonas 
[109], and Salmonella [110]. One of the most commonly studied MEP systems in F. tularensis 
is known as the AcrAB/TolC efflux pump [23]. The MEP is composed of IM AcrAB  [111] 
and OM TolC components [88, 91]. The importance of this system, specifically TolC subunit, 
is due to its activity toward antibiotics such as ß-lactam, tetracycline, aminoglycoside, and 
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quinolone and also toward detergents including bile salts and dyes effective against Gram-
negative bacteria [88, 91, 111]. In vivo studies have shown that disrupting the MEP subunits 
leads to attenuation of virulence in mice [88, 91, 111]. 
 There are two categories of the MEP: the ATP-binding cassette (also known as ABC) 
transporters and the secondary transporters [112]. The fuel for ABC transporter depends on 
Adenosine triphosphate (ATP) while the secondary transporters depend on either sodium or 
protons electron gradients [112]. Furthermore, the secondary transporters are further 
subcategorized into four super-families according to their compositional similarities [84]. 
These four subcategories are: major facilitator superfamily (MFS), resistance nodulation 
division (RND) family, multidrug and toxic compounds extrusion (MATE) family, and small 
multidrug resistance (SMR) family [84] (Figure 5). While the RND superfamily is specific for 
most Gram-negative organisms, the other efflux pumps can be found in any of Gram-positive 
or negative organisms [113].  
 Studies have found that 31 MFS transporters are encoded by F. tularensis genome 
[112] and the virulent strain Schu S4 has 15 active ABC transporters that are detected in silico 
[114]. In a study of LVS multidrug transporter, AcrAB RND, the AcrB subunit was categorized 
as an important virulence factor in mice along with its essential role in antibiotics and 
antimicrobial peptides avoidance [111]. However, another study using Schu S4 subspecies 
demonstrated that not only AcrB is required for drug resistance, AcrA also plays an important 
role in the efflux of dyes and detergents but not for virulence in mice [115].  
Interestingly, an additional role of the multidrug efflux pump is the involvement in 
resisting the oxidative stress mechanism [116-118]. Ma et al., (2014) reported that EmrA1 of 
F. tularensis LVS contributes to virulence in mice as it influences the production of the 
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antioxidant enzymes, SodB and KatG, that are required for resisting oxidative stress and thus, 
intramacrophage survival. [112]. acrB and tolC mutants, however, secreted SodB or KatG 
enzymes as detected in the culture filtrate and also did not show any susceptibility towards 
oxidants, yet, only sensitive to detergents and dyes [88, 111, 115]. 
The AcrAB/TolC efflux pump is regulated by the AcrR transcriptional regulator (a 
repressor) [113], which is a member of the TrtR family transcriptional regulators present in 
most bacteria that contain helix-turn-helix (HTH) domain specific for DNA binding [119]. 
This DNA binding motif is substantially conserved in most of TrtR family members [119]. In 
addition, proteins encoded by members of TrtR family regulate several genes that are required 
for resisting multidrugs and osmotic shock, catabolic enzymes, antibiotics biosynthesis, and 
virulence of most bacteria [119]. Hence, TrtR family members are essential for bacterial 
adjustment to various surrounding conditions [119]. Furthermore, AcrAB efflux pump was 
found to be activated by members of the AraC/XylS family; MarA, SoxS, and Rob [120-122]. 
However, they are not required for regulating the efflux in response to bacteria stress [123-
128]. Studies suggested that during stress, the expression of acrAB is regulated by a unique 





Figure 5. Superfamilies of bacterial efflux pumps and their substrates. Modified from 





1.5.1. F. tularensis transcriptional regulators 
Francisella possesses very few transcription regulators. A majority of these has been 
shown to regulate genes involved in virulence [130]. In general, bacteria produce transcription 
factors that bind to either specific or nonspecific DNA domains. The determination of whether 
the transcription factor is a repressor or activator depends on where the binding domain is 
located and on its sequence contents [130]. Transcriptional regulators are affected by several 
environmental factors such as high or low temperature, iron availability, oxidative pressure, 
and other antimicrobial compounds within macrophages. However, the molecular pathway 
behind the regulation needs further studies [130]. 
Three transcriptional regulators regulate FPI: MglA (macrophage growth locus protein 
A), SspA (stringent starvation protein A), and PigR (pathogenicity island gene regulator) [131, 
132]. MglA and SspA are members of SspA family, and they function as a heterodimer that 
attaches to RNA polymerase (RNAP) [131, 133, 134] to regulate expression of virulent genes 
[135]. The SspA-MglA complex was also found to be involved in the bacterial response to 
stringent amino acid starvation leading to alarmone release, which is a guanosine-
pentaphosphate ((p)ppGpp) [136]. PigR, or FevR (Francisella effector of virulence regulation) 
[130] in F. novicida, is a DNA binding protein that is recruited to the SspA-MglA-RNAP 
complex [132, 137]. It associates with the SspA and MglA to upregulate expression of other 
virulence genes that are not in the FPI [135]. In addition, about 100 genes that might be virulent 
were found to be regulated by SspA-MglA-PigR [136, 138]. fevR/pigR are positively regulated 
by MigR (macrophage intracellular growth regulator or also known as CaiC) to manipulate 
FPI gene expression. As most transcriptional regulators have DNA binding domain [139], 
MigR lacks this domain but still regulates the transcription of fevR/ pigR indirectly by 
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interacting with either of two genes: RelA or SpoT (stringent response regulators), which leads 
to the production of alarmone and thus controls fevR expression for virulence mechanism 
[130].  
Studies have shown that response to the stringent starvation is not only exclusive to the 
binding of PigR to the complex, another transcriptional regulator, known as PmrA, was also 
found to be involved. PmrA is a DNA binding protein too that is homologous to that in 
Salmonella spp. where it functions as a response regulator of the two-component system (TCS) 
[140]. It is phosphorylated by the histidine kinase KdpD at the PhoP phosphorylation site 
(Asp51) [141] to form a member of the orphaned TCS in F. tularensis [130]. Another member 
of the TCS in F. tularensis is QseC that contributes to the virulence mechanism and regulation 
[140, 142]. Therefore, F. tularensis activates the TCS (PmrA and KdpD) leading to the binding 
of PmrA to promoters and then to the MglA-SspA-RNAP complex or freeing RNAP to 
regulate virulence gene transcription [143]. 
Besides the above-mentioned transcriptional regulators, iron limitation causes stress on 
F. tularensis that requires the presence of specialized ferrous transcriptional regulator to 
manipulate iron gene expression. Fur is a ferric uptake regulator that binds to ferrous iron, 
when available, to downregulate iron genes [130]. These genes are upregulated by Fur in case 
of the iron-limiting environment [130]. They are located downstream of fur in F. tularensis 
and are known as F. tularensis siderophore locus (fsl) or F. tularensis iron genes (fig) [144, 
145].  
In addition to iron availability, temperature fluctuation during Francisella infection is 
another environmental stress. Before entering warm-blooded hosts (37°C), Francisella can 
survive in a 25°C environmental temperature and subsequently requires to adapt by modifying 
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the Lipid A composition of its LPS [146]. Studies demonstrate that F. tularensis has only two 
sigma factors (the housekeeping σ70 and the stress-related σ32), unlike E. coli and Bacillus 
subtilis that have six to eight sigma factors [130]. σ32 in F. tularensis is known as RpoH and is 
responsible for inducing the heat shock proteins [147-149]. Interestingly, several heat shock 
and virulence proteins of F. tularensis LVS are induced when exposed to higher temperatures 
[130]. Nevertheless, only 13 of the upregulated genes have a promoter binding site for σ32, and 
none of these genes is located in the FPI [149]. This indicates that there is an indirect path of 
σ32 to regulate virulence genes [130]. 
Another crucial transcriptional regulator in F. tularensis that is involved in the 
oxidative stress resistance is known as OxyR, which is a member of LysR transcriptional 
regulator family [150]. Like most of transcriptional regulators, members of this family has an 
HTH motif in the N-terminal and a regulatory domain in the C-terminal [150]. In several 
bacteria, the regulation of oxidative stress is manipulated by many regulators including OxyR, 
SoxR, PerR, and RNA polymerase of stationary phase (RpoS) [151]. Other regulators that act 
on resisting oxidative stresses, especially to reduce the effect of RNS and iron-sulfur 
development, include NorR and IscR [152]. E. coli overcomes hydrogen peroxide (H2O2) 
toxicity, heat shock, oxidative stress, and death by phagocytosis by regulating essential genes 
using the transcriptional regulator OxyR [153]. This requires oxidation of Cys199 and Cys208, 
conserved loci, as a result of H2O2 stimuli [154]. SoxR, on the other hand, is involved in 
resistance of superoxide radicals, nitric oxide (NO), or H2O2 at higher concentrations [155]. F. 
tularensis, as revealed from sequencing, has OxyR and RpoS homologs only when it lacks 
SoxR/SoxS regulators [98]. OxyR in F. tularensis plays a central role in regulating the genes 
that are essential for ROS and oxidative stress resistance as well as bacterial survival and the 
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virulence mechanisms in vivo [156]. OxyR binds directly to the promoter regions of 
antioxidant enzyme genes alkyl hydroperoxidase (ahpC) and catalase (katG)  to regulate their 
expression [156]. 
Additionally, by analyzing the genome of F. tularensis, we have identified a novel 
transcriptional regulator that is homologous to AraC regulators present in other Gram-negative 
bacteria. The AraC regulator belongs to the commonly known positive transcriptional 
regulators, the AraC/XylS family. They are characterized by the presence of high sequence 
similarity of amino acids that are expanding for a length of 100-residues to form two HTH 
DNA binding motif. This motif is unique and conserved among AraC/XylS family members. 
The first detected and biochemically studied AraC transcriptional regulator is the one that 
controls L-arabinose operon in E. coli. It functions as an activator of the araBAD operon as 
well as others, araFGH and araE [139], to manipulate L-arabinose utilization and catabolism 
[157] (Figure 6).  
AraC regulator has also been identified in  Erwinia chrysanthemum, Citrobacter 
freundii, and Salmonella and functions similarly to that of the E. coli. Members of the 
AraC/XylS family are involved in the regulation of several mechanisms in bacteria. Some of 
them control the metabolic functions of specific elements including carbon, amino acids, 
alcohol, and herbicides. Others are responsible for regulating the secretion of virulence 
proteins such as siderophores, urease, and those required for attachment to epithelial cells, 
composing cellular capsule, or invasion. Some members of the AraC/XylS family also play a 
central role in regulating bacterial response to alkylating agents, oxidative stress, antibiotics, 
and other stress environments [139].  Nonetheless, the role of AraC regulator in F. tularensis 





Figure 6. Schematic diagram of  transcriptional regulation of L-arabinose operon by 
AraC in E. coli. (a) AraC monomer structure. (b) When arabinose is absent, two AraC 
monomers bind to I1 and O2 causing  DNA to bend and form a loop that halks transcription 
of araBAD by RNA polymerase. (c) When arabinose is available, allosteric changes will 
occur in AraC dimer resulting in the release of the O2 site and binding of the dimer to I1 and 
I2 .This will facilitate RNA polymerase transcription of araBAD. Modified from Yang et 




2. HYPOTHESIS AND SPECIFIC AIMS  
 
Several studies have devoted enormous efforts to understand how F. tularensis avoids host  
defense mechanisms, replicates within an extremely secure immune system, and eventually 
causes the deadly disease tularemia. The extremely high virulence of Francisella depends on 
its ability to manipulate gene expression according to the surrounding environment. This process 
requires the involvement of unique transcriptional regulators. Francisella possesses very few 
transcriptional regulators, and a majority of them characterized to date has been shown to regulate 
genes involved in virulence and cellular functions. The role of a transcriptional regulator of F. 
tularensis belonging to the AraC/XylS in gene regulation and virulence remains uncharacterized 
to date. 
 
The goal of this study was to characterize the role of AraC as a transcriptional regulator in F. 
tularensis. Previous studies focused on understanding the role of AraC transcriptional regulator 
in E. coli reported that araC encodes a protein that is required for regulating arabinose 
utilization genes [130-134]. Other studies, on the other hand, found that members of the AraC 
family of transcriptional regulators are involved in regulating virulence-associated genes. 
[110]. This study aimed at characterizing the novel role of AraC as a transcriptional regulator 
in F. tularensis. In several Gram-negative bacteria, araC is transcribed divergently from and 
controls araBAD operon. While in F. tularensis, it is transcribed divergently from an operon 
encoding EmrA MEP. Thus, the overall hypothesis set forth was: “AraC may have a unique 
role in transcriptional regulation of multidrug efflux pump genes in addition to the genes 
involved in general metabolism as well as the stress response.” The following specific aims 
were proposed to address this hypothesis: 
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Specific Aim 1: Phenotypic characterization of the araC gene deletion mutant (ΔaraC) of 
F. tularensis LVS. AraC transcriptional regulator is known in most Gram-negative bacteria 
for its role in regulating the araBAD operon. Because the role of araC in F. tularensis has not 
been defined, in this study several potential functions of araC were to be examined to 
determine the exact role of this gene. A clean gene deletion mutant (ΔaraC) and the 
transcomplemented strain (ΔaraC+paraC) of F. tularensis LVS were generated and 
characterized for the role of AraC in 1) sugar utilization and metabolism; and 2) resistance to 
oxidative stress and antibiotics due to its proximity to the genes encoding Emr MEP. 
Specific Aim 2: Investigation of the role of AraC as a global transcriptional regulator in 
F. tularensis LVS.  The role of AraC as a transcriptional regulator in F. tularensis was 
determined by 1) deep RNA sequencing analysis to obtain a signature expression profile of 
genes in ΔaraC mutant in presence or absence of oxidative stress; 2) confirmation of 
differentially expressed genes by quantitative real-time PCR; and 3) establishing the role of 
AraC in transcriptional regulation of differentially expressed genes in intramacrophage 
survival and virulence in mice.  
The results from these studies were expected to provide comprehensive information regarding 
the genes that were under the control of AraC in absence or presence of oxidative stress. It was 
also our expectation that these studies would uncover the role of AraC in transcriptional 




3. MATERIALS AND METHODS 
3.1. Bacterial strains 
 The bacterial strains used in this study are listed in Table 1. The wild type F. tularensis 
LVS used in this study was obtained from BEI Resources, Manassas, VA. The deletion mutant 
of araC (FTL_0685) gene (ΔaraC) of F. tularensis LVS and its transcomplemented strain 
(ΔaraC+paraC) were generated in Dr. Meenakshi Malik’s laboratory at Albany College of 
Pharmacy and Health Sciences (ACHPS), Albany, NY. A transposon insertion mutant in 
emrA1 gene of F. tularensis LVS  available in our laboratory and used in previously published 
works was also used in this study. The E. coli DH-5α and S17 strains were obtained from 
Invitrogen.  
 The Francisella strains were cultured on Mueller-Hinton (MH) chocolate agar plates 
(BD Life Sciences) and incubated for 48 hours at 37οC and 5% CO2. Individual colonies were 
selected and inoculated at MH broth (MHB) enhanced with Isovitalex (BD Biosciences, San 
Jose, CA), Ferric Pyrophosphate, Glucose, Anhydrous Calcium Chloride, and Hydrous 
Magnesium Chloride. The bacterial cultures were incubated at 37οC with constant shaking 
until the bacterial growth reached the mid-log-phase. Bacterial aliquots were snap-frozen in 
liquid nitrogen and stored at -80οC. The emrA1 mutant was grown on MH Chocolate agar 
plates, or MHB supplemented with Kanamycin (10µg/ml). For the transcomplemented strain 
(ΔaraC+paraC), Hygromycin (100µg/ml) was added to the media instead of Kanamycin. All 




Table 1. List of bacterial strains, plasmids, and primers used in this study 





Strains   
F. tularensis LVS Wild type strain ATCC 
F. tularensis ΔaraC 
mutant 
Deletion mutant of araC gene of F. tularensis LVS  This study 
(Dr.  Malik’s 
Lab.) 
F. tularensis emrA1 
mutant 
LVS FTL_0687::Tn5 Kanr [112] 
F. tularensis araC 
transcomplemented 
strain (ΔaraC+paraC) 





E. coli  F–Φ80lacZΔM15Δ(lacZYA-argF) U169 recA1 
endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 
gyrA96 relA1 
Invitrogen 
   
Plasmids   
pMP822  E. coli-Francisella shuttle vector, Hygror [159] 
pJC84 E. coli-Francisella suicide vector, Kanr [160] 
pMM03 pJC84 + fused flanking fragment of araC gene, Kanr This study 
pMM014 pMP822 + araC, Hygror This study 
   



















   
Primers for confirmation 
















MP192 5’-ATGGGTGTTGCCATCAAATAGG-3’  
MP193 5’-TGTTGTCGCCAACGTGAAA-3’  












   










































   
dnaJ MP564 
MP565 
5’- GCCAAGGTACTATTCGTAGACAAC -3’ 
5’- ATTAGAGCCAGAATCACCCTCA -3’ 
 








3.2. Construction of ΔaraC gene deletion mutant of F. tularensis LVS 
 The plasmids and primer sequences used for generation and confirmation of the 
deletion mutant of F. tularensis araC gene and the transcomplemented strain are listed in 
Table 1. pJC84 suicide vector that allows for SacB-dependent allele replacement was used as 
reported earlier [160] for the generation of in-frame gene deletion of araC gene (FTL_0689) 
in F. tularensis LVS. For deletion of araC gene, a 5’ fragment composed of a 1152bp sequence 
from upstream to the start codon of FTL_0689 to the start codon was amplified by PCR using 
MP135 and MP137 primers. In addition, a 3’ fragment of a 2081bp from downstream of 
FTL_0689 to the stop codon was also amplified by PCR using MP139 and MP140 primers. By 
overlapping extension PCR using Pfx enzyme with primers MP135 and MP140, both 
fragments were merged to generate a larger fragment (2233bp). Since MP135 contained a 
BamH1 site and MP140 with a SalI site, the merged fragment was cloned into the BamH1 and 
SalI sites of pJC84 to generate pMM03. After that, PCR confirmation is performed. For 
electroporation, F. tularensis  LVS were cultured in MH-chocolate agar plate for 48 hours at 
37οC with 5% CO2. A starting OD600 of 0.05 F. tularensis LVS colonies was prepared in a 30 
ml MHB and incubated at 37οC with shaking. Once the suspension reached an OD600 of 
approximately 0.5, the bacteria were centrifuged at 4οC for 5 minutes at 4000 g. Then, the 
supernatant was discarded; the pellet was resuspended in the same volume of 0.5M sucrose 
solution for washing and then resuspended in 100µl of 0.5M sucrose solution. After that, 1µg 
of pMM03 was added to the bacterial suspension and incubated on ice for 10 minutes. 
Electroporation was conducted using an Eppendorf Eporator at 2,500 V, 200Ω, 25µF. 
Immediately after electroporation, 1ml of pre-warmed MHB was added and bacteria were 
incubated for another 2-3 hours at 37οC with agitation. Then, the electroporated bacteria were 
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centrifuged at 4οC for 5 minutes at 4000 g and resuspended in 100µl of 0.2M KCL. The bacteria 
were selected for antibiotic resistance on MH-chocolate agar plates containing 25µg/ml 
kanamycin. Following that, sucrose counterselection was performed by growing 0.5 OD600 of 
independent kanamycin resistant clones on MHB at 37οC with shaking and then supplemented 
with sucrose solution to make a final concentration of 5% and incubated for additional 2 hours.  
 After incubation, the bacteria were serially diluted and plated on MH-chocolate agar 
supplemented with 8% sucrose and incubated at 37οC with 5% CO2 for 48 to 72 hours. To 
verify loss of Kanamycin resistance marker, sucrose resistant clones were streaked into MH-
chocolate agar plates containing 25µg/ml Kanamycin. The sucrose resistant and Kanamycin 
sensitive clones were screened for the loss of araC gene using PCR. For araC gene deletion 
confirmation, a duplex colony PCR was performed using the primer sets: araC gene specific 
(MP192/MP193) and internal control-sodB gene (MP037/MP038) (Figure 7). To confirm the 
in-frame FTL_0689 deletion, we conducted genomic DNA sequencing for PCR positive 
clones. 
 For the transcomplemented strain (ΔaraC+paraC), the sequence of F. tularensis araC 
gene was amplified using the primers MP372 and MP373 with the enzyme Pfx. BamHI and 
XhoI restriction enzymes were used to digest the amplified sequence and then cloned into 
E.coli-Francisella shuttle vector pMP822 [159] to generate pMM014. This plasmid was then 
confirmed using PCR and DNA sequencing and was electroporated into ΔaraC mutant at 2,500 
V, 200Ω, 25µF. To confirm the transcomplementation of araC gene, the bacteria were selected 
in MH-chocolate agar plates containing 200µg/ml hygromycin. The hygromycin-resistant 





Figure 7. The genomic organization of the araC gene (FTL_0689) of F. tularensis LVS. 
The gene presents upstream of the three MEP genes emrB, emrA1, and silC. The grey arrows 
represent the location of the primers used to screen araC gene deletion.  
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3.3. Determination of the role of AraC in sugar utilization 
 The AraC of F. tularensis LVS was evaluated for its role in arabinose sugar utilization. 
Two different experiments were approached by growing the bacteria on MH chocolate agar 
plates with or without the sugars and by generating growth curves in the presence or absence 
of sugars. 
 
3.3.1. Growth in arabinose versus glucose containing chocolate agar 
 Mueller Hinton (MH)-chocolate agar plates containing glucose or arabinose sugars 
were prepared in our lab. Wild type F. tularensis LVS or ΔaraC mutant were grown overnight 
in MHB at 37οC with shaking. Bacteria were washed twice using 1×Phosphate-Buffered Saline 
(PBS) to remove any excess growth media. E. coli DH-5α or E. coli S17 used as positive 
controls. Bacteria were streaked on MH chocolate agar plates supplemented with 1% glucose 
or 1% arabinose and incubated 37οC with 5% CO2 for 48 hours. The bacterial growth pattern 
of ΔaraC mutant was compared to that of the controls. 
  
3.3.2. Bacterial growth curve using Chamberlain’s Defined medium (CDM) 
 A chemically defined medium known as Chamberlain’s medium was prepared as 
described previously [161]. The sugar concentration in the CDM was 0.4% and the media were 
prepared at three different conditions: 1) +glucose/-arabinose, 2) -glucose/+arabinose, and 3) 
-glucose/-arabinose. F. tularensis LVS or the ΔaraC mutant were cultured at 37οC with 5% 
CO2 for 48 hours and washed twice with 1× PBS before inoculated into CDM. Bacteria at 0.2 
OD600, which corresponded to 1×109 CFU/ml, were inoculated into the CDM and incubated at 
37οC with shaking. OD600 was recorded every 4 hours, and growth curves were generated using 
39 
 
GraphPad Prism 6 software.   
 
3.4. Disc diffusion assays 
 Disc diffusion assay, also known as Kirby-Bauer assay for antibiotic sensitivity testing, 
is a technique using sterile paper discs containing antibiotic or any other compound to 
determine bacterial sensitivity to that specific antibiotic/compound. F. tularensis LVS or the 
∆araC mutant was grown on MH-chocolate agar plate and incubated for 48 hours at 37οC and 
5% CO2. The bacterial suspension was prepared using sterile 1× PBS and adjusted to 2.0 OD600. 
A thick bacterial layer was spread on MH chocolate agar using sterile cotton swabs (Puritan 
Medical Products Company, Guilford, Maine). Antimicrobial susceptibility test discs 
including: Polymyxin B (300IU/IE/UI), Nalidixic acid (30µg), Chloramphenicol (30µg), 
Streptomycin (10µg), Erythromycin (15µg), Gentamycin (10µg), Novobiocin (30 µg), or 
Tetracycline (30µg) (BD BBL™ Sensi-Disc™) were placed over the bacterial lawn and 
incubated at 37 ºC and 5% CO2 for 48 hours or until bacterial lawn was thick enough to observe 
antibiotic sensitivity indicated by a zone of clearance around the disc. Using a ruler, the 
bacterial sensitivity was determined by measuring the zone of inhibition around antibiotic discs 
(in mm). If the bacterial susceptibility to a certain antibiotic is more, a larger zone of inhibition 
is formed around that antibiotic disc. 
 
3.5. Determination of the sensitivity of F. tularensis ΔaraC mutant to oxidants  
 The sensitivity of the ΔaraC mutant to various oxidants was determined using bacterial 
killing assay and by generating bacterial growth curves as described above. The bacterial 
growth curve used for bacterial sensitivity was generated using MH-broth, instead of CDM. 
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3.5.1. Bacterial killing assay 
 The bacterial killing assay is a direct method to determine the sensitivity of the bacteria 
to certain oxidative compounds. The procedure was performed according to the previously 
published protocols from our lab [112, 162, 163]. In brief, peroxides [1mM H2O2, tert-butyl 
hydroquinone (TBH) and cumene hydroperoxide (CHP)] or superoxide-generating compounds 
(20 mg/ml menadione, 50 mg/ml pyrogallol, 50 mg/ml paraquat) were serially diluted in a 96 
well-plate using MHB or 70% ethanol in case of CHP and paraquat. Wild type F. tularensis 
LVS or the ΔaraC mutant was adjusted to 0.2 OD600, and an equal amount of bacteria were 
added to each well containing the serially diluted compounds. The 96 well-plate was incubated 
for 1 and 3 hours at 37οC and 5% CO2 and then the bacteria were spotted on MH-chocolate 
agar plates using a multichannel pipette. In another approach, bacterial suspensions were 
exposed to H2O2, pyrogallol, or paraquat for 1 hour with shaking at 180 rpm and 37οC. Bacteria 
were serially diluted (10-fold) and plated on MH chocolate agar for 48 hours at 37οC and 5% 
CO2. Colony forming units (CFUs) of bacteria were counted and plotted as Log10 CFU/ml. 
 
3.5.2. Cell culture assay 
 Murine Raw 264.7 macrophage cells (1x106 cells/well) were seeded in a 24-well tissue 
culture plate.  Dulbecco's Modified Eagle's medium (DMEM) (Corning, without  L-glutamine 
and Sodium Pyruvate) was used in this experiment and was supplemented with 10% heat-
inactivated Fetal Bovine Serum (FBS),  2% L-glutamine, and 1% Sodium Pyruvate. The cells 
were infected with F. tularensis LVS or the ΔaraC mutant at a multiplicity of infection (MOI) 
of 1, 10, 100, or 500. Cells were centrifuged for 10 minutes at 1000 rpm to synchronize 
bacterial infection and incubated at 37οC and 5% CO2 for 4 and 24 hours. Two hours post-
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infection, medium from the infected cells was replaced with DMEM containing gentamycin 
(250µg/ml) to kill extracellular bacteria and was replaced with DMEM without any antibiotics 
after one hour of incubation. The cells were lysed with 0.1% sodium deoxycholate at 4 and 24 
hrs post-infection and then (10µl) of 10-fold serial dilution of the lysed cells was spotted on 
MH chocolate agar plates for enumeration of bacterial CFUs. Plates were incubated at 37οC 
and 5% CO2 for 48 hours and figure was generated using GraphPad Prism 6 software (Figure 
8). 
 
3.6. Mouse survival studies 
 The role of AraC in virulence was investigated by infecting wild type C57BL/6 mice 
with F. tularensis LVS or the ΔaraC mutant intranasally after anesthetizing them through 
intraperitoneal injection of ketamine and xylazine. Mice were inoculated with four different 
doses (1x102, 1x103, 1x104, or 1x105 CFUs) in a volume of 20µl (10µl/nare) of F. tularensis 
LVS or the ΔaraC mutant. Morbidity and mortality of the infected mice were observed for 15 
days. Body weight and survival were recorded daily. Survival was expressed as the Kaplan-






Figure 8. Design of macrophage cell culture assay.  




Figure 9. Mouse survival studies. C57BL/6 mice were infected with varying doses of F. 
tularensis LVS and the ΔaraC mutant intranasally (n=5 mice/bacterial strain). Morbidity 





3.7. RNA extraction  
 To determine the role of AraC as a global transcriptional regulator, we profiled whole 
transcriptome of the ΔaraC mutant in response to oxidative stress. This technique provides an 
quantitative measurement of RNA expression level [164] during oxidative stress. The 
superoxide-generating compound, menadione, was used for treatment. Menadione (20 mg/ml) 
was dissolved in 70% ethanol and filtered using 0.2m syringe filter (MILLEX-GP, Millipore 
Express PES membranes, Millipore Ireland Ltd, Cork, IRL). F. tularensis LVS or the ΔaraC 
mutant were suspended in MHB (0.2 OD600), and menadione was added for a final 
concentration of 1.25mM. For untreated control, MHB was added alternatively, and bacterial 
tubes were incubated for 1 hour at 37οC with 5% CO2. Bacteria were then centrifuged at 10000 
rpm for 10 minutes at room temperature, and pellets were resuspended in 990 µl lysis buffer 
(from Purelink RNA mini kit/Invitrogen) supplemented with 10µl 2-mercaptoethanol 
following the manufacturer’s protocol. The bacteria were then lysed by vortexing, and 1 ml 
TRIzol reagent (InvitrogenTM) was added to the lysate and mixed well. The lysate was 
incubated at 25οC for 4 minutes. Cold chloroform was added to the lysate and mixed well. The 
mixture was incubated for 2-3 minutes and centrifuged at 12000 rcf for 15 minutes at 4οC until 
an aqueous colorless solution containing the RNA is separated. After transferring the clear 
solution into another tube, isopropanol was added, mixed, and incubated for 10 minutes at 
room temperature. After that, the Spin cartridges with the collection tubes supplemented with 
the kit were used to purify RNA. RNA samples were treated with DNase using InvitrogenTM 





3.8. RNA sequencing 
 Purified RNA samples were sent to the Genomics Core Laboratory at the New York 
Medical College for sequencing. Differentially expressed genes were evaluated based on 
log2(fold change) value. The differential expression of F. tularensis LVS and ΔaraC mutant 
genes was analyzed based on log2(fold change) of genes in the ΔaraC mutant as compared to 
those in wild type F. tularensis LVS in the untreated, and the menadione treated samples. For 
the downregulated genes, the expression of the araC gene which has been deleted in the 
ΔaraC mutant was taken as 100%. Any gene that represented less than 50% of the log2(fold 
change) of the araC gene was considered as downregulated. However, to further narrow the 
number of genes identified as under the control of AraC, we considered the p-values and any 
value less than 0.05 was considered significant. All the data analyzed were cumulative of two 
independent experiments (Figure 10). 
 
3.9. Quantitative real-time polymerase chain reaction (qRT-PCR) 
qRT-PCR was used to confirm differentially expressed genes from the RNA 
sequencing experiments. Gene-specific primers used for qRT-PCR are listed in Table 1. All 
qRT-PCR experiments were performed using 96-well plates (MicroAmp Optical 96-Ell 
Reaction Plate, Applied Biosystems, Inc., Foster City, CA, USA). Samples denaturation, 
reverse transcription, and amplification were conducted using a 7500 Fast Real-Time PCR 
System (Applied Biosystems, Inc., Foster City, CA, USA). The CT (cycle threshold) values of 
both F. tularensis LVS and the ΔaraC mutant were provided by the qRT-PCR instrumentation. 
These CT values are readily imported into Excel sheets to calculate ΔCT of each of the wild 
type and ΔaraC mutant for every tested gene. For example, if we assumed that the wild type 
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F. tularensis is A and the ΔaraC mutant is B, then the calculations are: ΔCTA= CT (target) A-CT 
(control) A and ΔCTB= CT (target) B- CT (control) B. Next, the ΔΔCT was calculated for every target 
gene using the formula: ΔΔCT= ΔCTB- ΔCTA. After that, expression normalization was 
calculated as 2-(ΔΔ CT). This indicated the fold change in gene expression of the ΔaraC mutant 
as compared to the F. tularensis.   
 
3.10. Statistical analysis 
 All results were analyzed using GraphPad Prism 6 software and were represented as 
Mean ± Standard Deviation (SD). Comparisons among experimental groups were made using 
one-way ANOVA. Survival data were plotted as the Kaplan-Meier survival curves, and 
significance was statistically calculated by the Log-rank test.  The statistically significant data 

















 The primary goal of this study was to investigate the role of AraC as a transcriptional 
regulator of F. tularensis, and to understand its role in tularemia pathogenesis. In literature, 
AraC has been reported to be a member of the AraC/Xyls transcriptional regulator family  [139, 
165-167]. AraC has been shown to regulate L-arabinose metabolism in E. coli and serves both 
as an activator as well as a repressor [139, 168]. The role of AraC in F. tularensis LVS is not 
characterized to date. In this study, we elucidated the role of AraC in gene regulation of F. 
tularensis.  
 Our overall hypothesis was “AraC may have a unique role in transcriptional regulation of 
multidrug efflux pump genes in addition to the genes involved in general metabolism as well 
as the stress response.” We developed two specific aims to address our hypothesis. 
 
Specific Aim 1: Phenotypic characterization of the araC gene deletion mutant (ΔaraC) of 
F. tularensis LVS. 
4.1. The genomic organization of the araC gene of F. tularensis LVS 
 The genomic organization of araC gene is shown in Figure 11A. The araC gene of F. 
tularensis is transcribed divergently from the downstream operon encoding for components 
EmrB, EmrA1, and SilC of MFS type MEP (Figure 11B).  All the other Francisella strains 
including the virulent F. tularensis Schu S4 and F. novicida exhibit an identical genomic 
organization to that observed in F. tularensis LVS. A similar genomic organization is also 
present in Burkholderia pseudomallei (B. pseudomallei). In E. coli, Yersinia pestis, and 
Salmonella typhi, this gene is annotated as a transcriptional regulator rather than araC and is 
transcribed in a similar direction as the upstream genes.  Thus, the genomic organization of 
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araC gene in Francisella is unique. This also implies that AraC may have a unique role in 
tularemia pathogenesis.  
 Sequence comparison of AraC transcriptional regulator within Francisella subspecies 
revealed high similarity, ranging from 97% to 100%. However, AraC showed less homology 
when aligned with the transcriptional regulator present in a similar genomic location in other 
pathogenic bacterial species. Table 2 shows the identity percentage of some Gram-negative 
pathogenic bacteria, including B. pseudomallei (51.35 %), S. typhi (47.62 %), Y. pestis (42.42 
%), and E. coli (33.33 %), with the AraC amino acid sequence of F. tularensis LVS. We 
determined that the AraC amino acid sequence of F. tularensis is highly conserved in almost 
all Francisella subspecies. Multiple sequence alignment in Figure 12 using Clustal W 
demonstrated that AraC protein sequences of all the pathogens used in this alignment exhibited 
a conserved C-terminal domain (highlighted grey), with a consensus motif 
GxxxxxxFxxxxxxxxxxxP (G/F/P). This consensus sequence starts at amino acid 244 and ends 
at amino acid 263 of AraC (FTL_0689).  
Moreover, to demonstrate the protein binding motif logo sequence, we used one of the 
most commonly utilized software, Meme (Multiple Em for Motif Elicitation), a visually rich 
and informative logo representation of sequence alignment. The alignment identified the C-
terminal and N-terminal conserved sequences of AraC protein of F. tularensis LVS compared 
to E. coli AraC and Y. pestis VirF.  Figure 13A demonstrates the conserved DNA binding 
motif in the C-terminal domain, which is similar to the binding domain that we revealed using 
Clustal W. In addition, we identified two protein binding motifs located in the N-terminal. 
Figure 13B represents the signature motif of HPxM, and Figure 13C is the second binding 
motif WxH. These N-terminal domains are unique, present in AraC of a few pathogens 
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including all Francisella strains. Collectively, bioinformatic analysis of AraC suggests that 
AraC transcriptional regulator of Francisella is unique and may be responsible for a 





Figure 11. Generation of the ΔaraC deletion mutant. (A) Genomic organization of the F. 
tularensis LVS multidrug efflux pump (MEP) genes showing the presence of the araC 
transcriptional regulator upstream of this set of genes and is annotated as FTL_0689. (B) 
schematic diagram showing araC transcriptional regulator of F. tularensis (red box) is 
transcribed divergently from the MEP components (blue dashed box), unlike other 
organisms. (C) Deletion of araC and primer locations for the screening of araC mutant 
indicated by grey arrows. (D) Confirmation of araC deletion by the PCR. The wild type F. 






Figure 12. Protein sequence alignment of the AraC of F. tularensis and XylS/AraC 
family proteins from other pathogens. Multiple alignments were generated using Clustal 
W software. The C-terminal region (highlighted in grey) shows a conserved DNA binding 
motif GxxxxxxFxxxxxxxxxxxP (conserved residues are represented by red boxes and 
arrows). The numbers in the right indicate amino acids location.  
FTL_0689       -------M---------I---------------------REEITYLSDWLDGP------E 17 
FTT_1255c      MMKKGQSM---------I---------------------REEITYLSDWLDGP------E 24 
FTN_1274       -------M---------I---------------------REEITYLSDWLDGP------E 17 
E.coli GadX    ------------------------------------------------------------ 0 
E.coli AraC    --------------MAEAQNDPLLPGYSFNAHLVAGLTPIEANGYLDFFIDRPLGMKGYI 46 
S.typhi RhaS   -MTVLHSVDFFPSGKAPVAIEPRLPQAAFPEH----------------------HHDFHE 37 
E.coli SoxS    ------------------------------------------------------------ 0 
Y.VirF         -------M---A-SLEIIKLEWATPIFKVVEH------------------------SQDG 25 
P.ExsA         -MQGAKSL---G-RKQITSCHWNIPTFEYRVN------------------------KEEG 31 
                                                                            
 
FTL_0689       IIAIKGGNAPTSENKINNQESDWHHHRRGKIFCIESGLVHVSTPNGSWV------LPSNR 71 
FTT_1255c      IIAIKGGNAPTSENKINNQESDWHHHRRGKIFCIESGLVHVSTPNGSWV------LPSNR 78 
FTN_1274       IIAIKGGNAPTSENKINNQESDWHHHRRGKIFCIESGLVHVSTPNGSWV------LPSNR 71 
E.coli GadX    -MQSLHGNCLIAYA----RHKYILTMVNGEYRYFNGGDLVFADASQIRV-----DKCVEN 50 
E.coli AraC    LNLTIRGQGVVKN--------------QGREFVCRPGDILLFPPGEIHHYGRHPEAREWY 92 
S.typhi RhaS   IVIVEHGTGIHVF--------------NGQPYTISGGTVCFVRDHDRHLYEHTDNLCLTN 83 
E.coli SoxS    ------------------------------------------------------------ 0 
Y.VirF         LYILLQGQVSWQN--------------SSQTYDLDEGNMLFLRRGSYAVRCGTKEP--CQ 69 
P.ExsA         VYVLLEGELTVQD--------------IDSTFCLAPGELLFVRRGSYVVSTKGK-D--SR 74 
                                                                            
 
FTL_0689       AGWIPPNTSHKIRISGIVEGWVI-----FIHPNMCDD----------LPKSSRVIPMSEV 116 
FTT_1255c      AGWIPPNTSHKIRISGIVEGWVI-----FIHPNMCDD----------LPKSSRVIPMSEV 123 
FTN_1274       AGWIPPNTSHKIRISGIVEGWVI-----FIHPNMCDD----------LPKSSRVIPMSEV 116 
E.coli GadX    FVFVSRDTLS------LFLP-------MLKEEALNLHAHKKVSSLLVHHC-SRDIPVFQE 96 
E.coli AraC    HQWVYFRPRA------YWHEWLNW-PSIFA--NTG-----------FFRPDEAHQPHFSD 132 
S.typhi RhaS   VLWRSPDAFQ------FLAGLD----QLLPQEQDGY---Y--PS--HWRVNQSVLQQVRQ 126 
E.coli SoxS    ------------------------------------------------------------ 0 
Y.VirF         LLWIPL-PGS------FLSTFLHRFGSLLSEIRRDN---STPKPLLIFNISPILSQSIQN 119 
P.ExsA         ILWIPL-SAQ------FLQGFVQRFGALLSEVERCD---EPVPGIIAFAATPLLAGCVKG 124 
                                                                            
 
FTL_0689       LRALALRAT-EWDKYNNLSLEQEHIAKIICNEIRLAPEEAL--HLPMPKTDRVIKVANAI 173 
FTT_1255c      LRALALRAT-EWDKYNNLSLEQEHIAKIICNEIRLAPEEAL--HLPMPKTDRVIKVANAI 180 
FTN_1274       LRALALRAT-EWDKYNNLSLEQEHIAKIICNEISLAPEEAL--HLPMPKTDRVTKVANAI 173 
E.coi GadX     VAQLSQ---NKNLRYAEMLRKRALIFALLSVFLEDEHFIPLLLNVLQPN---MRTRVCTV 150 
E.coli AraC    LFGQIINAGQGEGRYSELLA--INLLE-QLLLRRMEA---I-NESLHPPMDNRVREACQY 185 
S.typhi RhaS   LVGLMERAGDGMDAPAVANRE-ILFMQ-LLVLLR---RSSL-ME-GATNNDAKLNQLMAW 179 
E.coli SoxS    -----------------------------------------------MSHQKIIQDLIAW 13 
Y.VirF         LCAILERSD----FPSVLTQ--LRIEE-LLLLLAFSSQGTLFLSALRHLGNRPEERLQKF 172 
P.ExsA         LKELLV-HE----HPPMLAC--LKIEE-LLMLFAFSPQGPLLMSVLRQLSNRHVERLQLF 176 
                                                                            
 
FTL_0689       IDN-P-SISKSLEQWAAFAAMSPRTLRRAFLSETGLSFSRWRQQAQLARGLDM-LAKDIS 230 
FTT_1255c      IDN-P-SISKSLEQWAAFAAMSPRTLRRAFLSETGLSFSRWRQQAQLARGLDM-LAKDIS 237 
FTN_1274       IDN-P-SISKSLEQWAAFAAMSPRTLRRAFLSETGLSFSRWRQQAQLARGLDM-LAKDIS 230 
E.coli GadX    INNNI-AHEWTLARIASELLMSPSLLKKKLREEET-SYSQLLTECRMQRALQLIVIHGFS 208 
E.coli AraC    ISDHLADSNFDIASVAQHVCLSPSRLSHLFRQQLGISVLSWREDQRISQAKLLLSTTRMP 245 
S.typhi RhaS   LEDHF-AEEVCWEAVAEQFSLSLRTLHRQLKQHTGLTPQRYLNRLRLIKARHLLRHSDHS 238 
E.coli SoxS    IDEHI-DQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERP 72 
Y.VirF         MEENY-LQGWKLSKFAREFGMGLTTFKELFGTVYGISPRAWISERRILYAHQLLLNCKMS 231 
P.ExsA         MEKHY-LNEWKLSDFSREFGMGLTTFKELFGSVYGVSPRAWISERRILYAHQLLLNSDMS 235 
               :..            :     .   : . :      :        ::  .           
 
FTL_0689       VTEVSDSLGYASPSNFIAMFRKAFGKTPKQYFSSERVQIKNIYKN--------------- 275 
FTT_1255c      VTEVSDSLGYASPSNFIAMFRKAFGKTPKQYFSSERVQIKNIYKN--------------- 282 
FTN_1274       VTEVSDSLGYASPSNFIAMFRKAFGKTPKQYFSSERVQIRNIYKN--------------- 275 
E.coi GadX     IKRVAVSCGYHSVSYFIYVFRNYYGMTPTEYQERSAQRLSNRDSAASIVAQGNFYGTDRS 268 
E.coli AraC    IATVGRNVGFDDQLYFSRVFKKCTGASPSEFRAGCEEKVNDVAVKLS------------- 292 
S.typhi RhaS   VTEIAYRCGFGDSNHFSTLFRREFNWSPRDIRQGRDAIIQ-------------------- 278 
E.coli SoxS    IFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL------------------------- 107 
Y.VirF         IVDIAMEAGFSSQSYFTQSYRRRFGCTPSQARLTKIATTG-------------------- 271 
P.ExsA         IVDIAMEAGFSSQSYFTQSYRRRFGCTPSRSRQGKDECRAKNN----------------- 278 
               :  :.   *: .   *   ::.  . :*                                 
 
FTL_0689       ------ 275 
FTT_1255c      ------ 282 
FTN_1274       ------ 275 
E.coli GadX    AEGIRL 274 
E.coli AraC    ------ 292 
S.typhi RhaS   ------ 278 
E.coli SoxS    ------ 107 
Y.VirF         ------ 271 




Table 2: F. tularensis LVS AraC sequence alignment with other bacterial strains 
Pathogen Locus tag Product Identity Accession 
F. tularensis subsp. 
tularensis Schu S4 
FTT_1255c 
AraC family transcriptional 
regulator 
99.65% YP_170213 








E. coli K-12 U069_c0078 








S. enterica subsp. 




26% AXR57446                 
Y. enterocolitica RLY99535                 
Virulence regulon transcription 
al activator VirF 
28% RLY99535                 






Figure 13. AraC binding motifs are conserved. (A) AraC C-terminal region showing the 
DNA binding domain (GxxxxxxFxxxxxxxxGxxP). (B and C) Protein binding motifs in the 





4.2. Generation of araC gene deletion mutant and the transcomplemented strain 
The araC in-frame gene deletion mutant (ΔaraC) of F. tularensis LVS was generated 
by an allelic replacement method and confirmed by PCR.  Primers internal to the araC gene 
amplified a fragment of 500 bp in the wild type F. tularensis LVS, while the absence of this 
amplicon indicated deletion of araC gene (Figure 11C and 11D).  The full-length araC gene 
was amplified in the transcomplemented strain indicating the restoration of the araC gene in 
the ∆araC mutant.  Primers specific to the sodB gene were used as internal control and a PCR 
fragment corresponding to the sodB gene was amplified in all the three strains tested, indicating 
that the absence of araC gene-specific fragment in the araC mutant is not due to the lack of 
input DNA. Furthermore, the in-frame gene deletion in the araC mutant was additionally 
confirmed by DNA sequencing (data not shown). 
 
4.3. Determining the involvement of AraC in L- arabinose utilization and metabolism  
To determine if AraC transcriptional regulator is responsible for L-arabinose 
metabolism, we tested the ability of the ΔaraC mutant to grow in the presence of L-arabinose 
containing media. We prepared MH-chocolate agar plates containing 10g of either the D-
glucose or L-arabinose. The plates were then streaked with F. tularensis LVS, the ΔaraC 
mutant, or the transcomplemented strain. Two strains of E. coli, DH-5α and S17.1, were used 
to serve as positive controls as both these strains can grow in the presence of arabinose. Our 
results demonstrated that the ΔaraC mutant, the wild type F. tularensis LVS, and the 
transcomplemented strain as well as E. coli DH-5α, and S17 strains were able to grow 
sufficiently in the presence of D-glucose (Figure 14A). However, all three F. tularensis strains 
showed traces of visible growth in the presence of L-arabinose, as compared to the E. coli 
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strains (Figure 14B). These results demonstrate that all F. tularensis LVS strains fail to grow 
in the presence of L-arabinose indicating that Francisella cannot utilize L-arabinose as a 
carbohydrate source and that D-glucose is the preferred sugar source for F. tularensis LVS. A 
trace amount of growth for the wild type F. tularensis, the araC mutant and the 
transcomplemented strains were observed when grown on MH-chocolate agar plates 
containing L-arabinose as the sole sugar source. This indicated that either the Francisella 
strains poorly utilize L-arabinose or that components of the MH-agar media were supporting 
this scant growth.  To address this notion, we generated bacterial growth curves using CDM 
with three different sugar compositions: one with neither glucose nor arabinose, one with D-
glucose only, and the other with arabinose as the sole carbohydrate source. Both the ΔaraC 
mutant and the wild type F. tularensis LVS grew very well in glucose-containing CDM 
(Figure 14C). Both strains grew at a similar rate and reached an approximate OD600 of 2.4 
after 40 hours of incubation. However, when the CDM was supplemented with L-arabinose 
only (Figure 14D) or with no sugar (Figure 14E), both the wild type and the mutant strains 
reached an OD600 of 0.5 after a short period of growth and then entered into a stationary phase, 
indicating their growth was largely affected by the lack of appropriate sugars in the medium. 
Collectively, these results demonstrate that D-glucose is essential for the growth of F. 
tularensis and it cannot utilize L-arabinose. Furthermore, these results also demonstrate that 





Figure 14. Growth of F. tularensis LVS strains in the presence of different 
carbohydrate substrates. The wild type F. tularensis LVS, the ΔaraC mutant, or the 
transcomplemented strains were grown in MH-chocolate agar containing glucose (A), or 
arabinose (B). E. coli DH-5α and E. coli S17.1 were used as positive controls. Growth curves 
of the wild type F. tularensis LVS and ΔaraC mutant in CDM supplemented with glucose 
(C), arabinose (D), or in the absence of sugar (E). (n = 3)  













































4.4. Investigating the role of AraC in the regulation of EmrA1 MEP components 
In the genomic organization (Figure 11A), araC of F. tularensis is divergently 
transcribed from the genes encoding major facilitator superfamily type multidrug efflux pump 
genes: emrB, emrA1, and silC. Such a unique organization indicated that AraC might be 
involved in the regulation of these downstream genes. Thus, we first tested the expression 
levels of emrB, emrA1, and silC genes in the ΔaraC mutant and compared them with those in 
the wild type F. tularensis LVS by qRT-PCR. The results shown in Figure 15 indicated that 
expression of all these three genes was significantly downregulated in the ΔaraC mutant in 
stark contrast to the wild type F. tularensis LVS, suggesting that AraC may have a role in the 
regulation of the components of the Emr multidrug efflux pump.  
 
4.4.1. The sensitivity of ΔaraC mutant to oxidants  
 We next investigated to confirm if the phenotype of the ΔaraC mutant is similar to those 
described for the emrA1 and ΔsilC mutants. EmrA1 is a membrane fusion protein and SilC is 
an outer membrane protein of major facilitator superfamily type MEP in F. tularensis LVS 
[87, 112].  Loss of both emrA1 and silC results enhanced sensitivity of these mutants towards 
oxidative stress. Therefore, we investigated if AraC contributes to the resistance of F. 
tularensis LVS towards oxidants via regulating MEP components emrA1 and silC. We 







4.4.1.1.  The araC mutant of F. tularensis LVS is sensitive to hydrogen peroxide 
To determine the sensitivity of ΔaraC mutant to peroxides, we used organic peroxides 
and H2O2 in a spot assay. The emrA1 mutant was used for a comparison. We performed 
bacterial killing assay by exposing wild type F. tularensis LVS, the ΔaraC mutant, the 
transcomplemented strain ΔaraC+paraC, and the emrA1 mutant to varying concentrations of 
H2O2, incubated for one and three hours, and plated on MH-chocolate agar to determine the 
bacterial viability. The results showed an enhanced killing of the ΔaraC mutant when exposed 
to increasing concentrations of H2O2 for one and three hours as compared to the wild type F. 
tularensis LVS. The transcomplementation restored the wild type phenotype and showed 
similar sensitivity after one and three hours of incubation. The emrA1 mutant showed an 
enhanced killing as compared to the wild type F. tularensis LVS after one hour of exposure to 
H2O2 (Figure 16A). These results indicate that ΔaraC mutant, similar to the emrA1 mutant, is 
sensitive to the increasing concentration of H2O2.  
We next performed the bacterial killing assay to quantitate the bacterial numbers after 
exposure to H2O2. We exposed wild type F. tularensis LVS, the ΔaraC mutant, the 
transcomplemented strain, and the emrA1 mutant (adjusted to an OD600 of 0.2) to 8 mM of 
H2O2, a concentration that had been demonstrated bacterial killing in spot assays. Ten-fold 
dilutions of the bacterial strains after one hour of exposure to H2O2 were then plated on MH-
chocolate agar plates. The results showed that about 40% of the ΔaraC and the emrA1 mutants 
were killed, which was significantly higher than the percentage of bacterial killing (28%) 
observed for the wild type F. tularensis LVS after one hour of exposure. The 
transcomplemented strain showed a significant increase in killing as compared to the wild type 
F. tularensis LVS and failed to restore the wild type phenotype possibly due to the loss of the 
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transcomplementation plasmid in the absence of antibiotic selection pressure (Figure 16B). 
Furthermore, the bacterial counts revealed an approximately 12-fold decrease in the viability 
of ΔaraC and the emrA1 mutants as compared to the wild type F. tularensis LVS (Figure 
16C). Collectively, these results demonstrate that loss of araC, similar to the emrA1 mutant, 





Figure 15. qRT-PCR analysis of silC, emrA1, and emrB genes. The data shown are 







Figure 16. The sensitivity of the araC mutant to H2O2. (A) Wild type F. tularensis LVS, 
the ΔaraC mutant, ΔaraC+paraC, or the emrA1 mutant were exposed to the indicated 
concentration of H2O2 for one hour and three hours in a spot assay. Experiments are 
representative of two independent experiments. (B and C) Bacterial killing assay using 8 
mM H2O2. The data were analyzed using one-way ANOVA. The data from the bacterial 





4.4.1.2. The ΔaraC mutant is sensitive to organic peroxides 
The sensitivity of the ΔaraC mutant was also determined against organic peroxide, 
TBH. Bacteria were exposed to varying concentrations of TBH, and the bacterial viability was 
determined by spot assay.  Bacterial viability was similarly reduced in both the wild type F. 
tularensis LVS and the ΔaraC mutant after 1 hour of exposure to TBH. However, after three 
hours of incubation, there was an enhanced killing of the ΔaraC mutant as compared to the 
wild type F. tularensis LVS, indicating that prolonged exposure of the ΔaraC mutant to TBH 
results enhanced sensitivity to TBH (Figure 17A).  
Next, we investigated sensitivity of the ΔaraC mutant to CHP.  The ΔaraC mutant 
exhibited enhanced sensitivity to CHP after one hour and three hours of exposure to CHP as 
compared to the wild type F. tularensis LVS (Figure 17B). We further confirmed these results 
by performing disc diffusion assay. Significantly larger zones of inhibition (11.25±0.25 mm) 
were observed for the ΔaraC mutant as compared to those observed for the wild type F. 
tularensis LVS (9.25±0.25 mm) and the transcomplemented strain (10.25±0.25 mm) when 
exposed to a 0.1M concentration of CHP. The difference was lost when a higher concentration 
of 0.5M of CHP was used (Figure 17C). Taken together, these results demonstrate that the 
ΔaraC mutant is highly sensitive to organic peroxides TBH and CHP. This phenotype has also 
been demonstrated for both the emrA1 and silC mutants of F. tularensis LVS as well as Schu 






Figure 17. Sensitivity of ΔaraC mutant to organic peroxides. Spot assay of F. tularensis 
LVS and the ΔaraC mutant at varying concentrations of TBH starting from 6.3 mM (A) and 
CHP starting from 0.7 mM CHP (B). Disc diffusion assay of the wild type F. tularensis 
LVS, the ΔaraC mutant, and the transcomplemented strain using the indicated 
concentrations of CHP (C). Zones of inhibition from bacteria treated with 0.25 M, 0.1 M, or 
0.5 M CHP are shown. The data shown in C are cumulative of two independent experiments 




4.4.1.3. The ΔaraC mutant of F. tularensis LVS is sensitive to superoxide-
generating compounds  
Both the emrA1  and silC  mutants are also sensitive to superoxide-generating 
compounds. Since we observed that the ΔaraC mutant had higher sensitivity towards 
peroxides, similar to the emrA1  and silC mutants, we also tested sensitivity of the ΔaraC 
mutant to superoxide-generating compounds pyrogallol, paraquat, and menadione.  
Enhanced killing of the ΔaraC mutant was observed when exposed to increasing 
concentrations of pyrogallol, at one and three hours post-exposure, as compared to the wild 
type F. tularensis LVS. The trans-complementation did not restore the wild type phenotype.  
The emrA1 mutant as reported earlier showed enhanced killing similar to the ΔaraC mutant 
after one and three hours of exposure to pyrogallol (Figure 18A).  
Next, we confirmed our observations by performing disc diffusion assay by exposing 
the wild type F. tularensis LVS, ΔaraC mutant, and the transcomplemented strain to sterile 
discs impregnated with 50mg, 25mg, or 12.5mg of pyrogallol. The plates were incubated, and 
zones of inhibition were measured in mm (Figure 18B). The ΔaraC mutant exhibited 
significantly larger zone of inhibition (19.00±0.41) as compared to that of the wild type F. 





Figure 18. Sensitivity of ΔaraC mutant to pyrogallol. (A) Spot assay of F. tularensis LVS, 
the ΔaraC mutant, ΔaraC+paraC, and the emrA1 mutant. Bacteria were exposed to a 
concentration gradient of pyrogallol for one and three hours and plated on MH-chocolate 
agar plates. (B) Disc diffusion assay using indicated concentrations of pyrogallol and zones 
of inhibition for 50 mg/mL concentration are shown.  The data shown are cumulative of two 




We also tested sensitivity of the ΔaraC mutant to superoxide-generating compound 
paraquat which generates superoxide radicals intracellularly. However, we did not observe any 
enhanced susceptibility of the ΔaraC mutant to paraquat when tested by spot assay, bacterial 
killing assay or the disc diffusion assay. Similar results were also observed for the emrA1 
mutant (Figure 19). Results similar to those observed for paraquat were obtained when the 
sensitivity of the ΔaraC mutant was tested against another superoxide-generating compound 
menadione (Figure 20). These results demonstrate that the ΔaraC mutant exhibits enhanced 
sensitivity only towards pyrogallol as compared to the wild type F. tularensis LVS but not 
towards paraquat or menadione. Moreover, the patterns of the sensitivity of the ΔaraC and the 
emrA1 mutant to pyrogallol and paraquat are identical. These results indicate that the 
sensitivity of the ΔaraC mutant to superoxide-generating compounds varies depending on the 
location and mechanism of generation of superoxide radicals. Taken together, these results 
demonstrate that the ΔaraC mutant exhibits an identical oxidant sensitive phenotype similar to 





Figure 19. Sensitivity of ΔaraC mutant to paraquat. (A) Spot assay of F. tularensis LVS, 
ΔaraC mutant, trans-complement, and emrA1 mutant. (B) percentage of bacterial killing and 
(C) CFUs after exposing to 0.5 mM paraquat, expressed as Log10 CFU/mL. (D) Disc 
diffusion assay using the indicated concentrations of paraquat. (E) Zones of inhibition 
measurement when bacteria were treated with 0.9 mg of paraquat, expressed in mm. The 
data shown are cumulative of three independent experiments. The data are analyzed using 





Figure 20. Sensitivity of ΔaraC mutant to menadione. (A) spot assay of ΔaraC mutant as 
compared to F. tularensis LVS. (B) Disc diffusion assay using the indicated concentrations 
of menadione. (C) Measurement of the zones of inhibition for bacteria treated with 1 μg 
menadione, expressed in mm. The data shown are cumulative of three independent 






4.4.2. AraC is not involved in resistance to silver compounds 
In addition to providing resistance to oxidants, EmrA1 and SilC also contribute towards 
resistance to silver compounds [87]. We tested sensitivity of the ΔaraC mutant to varying 
concentrations of silver nitrate in a spot assay to determine its contribution to resisting silver 
compounds. The results indicated no enhanced sensitivity of the ΔaraC mutant to increasing 
concentrations of silver nitrate as compared to the wild type F. tularensis LVS. However, the 
emrA1 mutant was found to be highly sensitive to silver nitrate following one and three hours 






Figure 21. Sensitivity of ΔaraC mutant to Silver nitrate (AgNO3). Spot assay of F. 
tularensis LVS, ΔaraC mutant, and emrA1 mutant. 25 mM of silver serially diluted in a 96-
well plate and incubated for one and three hours and plated using a replica plating method. 
The results are representative of three independent experiments conducted.  
   
72 
 
4.4.3. AraC is not involved in rendering resistance towards antibiotics 
The MEP components EmrA1 and SilC of the Emr multidrug efflux pump are required 
for efflux of antibiotics and antibiotic resistance [87, 112]. We further investigate if AraC, 
similar to EmrA1 and SilC, is involved in antibiotic resistance. We tested sensitivity of the 
ΔaraC mutant to Streptomycin (10 μg), Gentamicin (10 μg), Novobiocin (30 μg), 
Erythromycin (15 μg), Tetracyclin (30 μg), Nalidixic acid (30 μg), Polymyxin B (300 units), 
and Chloramphenicol (30 μg). As shown in Figure 22, the ΔaraC mutant was found to be 
equally sensitive to all the antibiotics tested as the wild type F. tularensis LVS. This result 







Figure 22. The ΔaraC mutant does not exhibit enhanced sensitivity towards antibiotics. 
Disc diffusion assay of the ΔaraC mutant and F. tularensis LVS using Streptomycin, 
Gentamicin, Novobiocin, and Erythromycin in (A), Tetracyclin, Nalidixic acid, Polymyxin 
B, and Chloramphenicol in (B). Measurement of zones of inhibition of the indicated 
antibiotics and their concentrations (C).  The results are cumulative of three independent 




Specific Aim 2: Investigation of the role of AraC as a global transcriptional regulator in 
F. tularensis LVS 
Our preceding results demonstrated the involvement of AraC in oxidative stress 
resistance. In Specific Aim 2, we investigated the genes that are being controlled by AraC 
transcriptional regulator. Activation of AraC/XlyS transcriptional regulators requires the 
presence of a substrate such as arabinose that activates them. Studies conducted in Specific 
Aim 1 failed to identify the specific substrate of AraC of F. tularensis. However, the ΔaraC 
mutant did demonstrate sensitivity towards oxidative stress. We hypothesized that “AraC of 
Francisella gets activated in the presence of oxidative stress and regulates the expression of 
genes required for survival under the oxidative stress conditions.” To address this hypothesis, 
we investigated the transcriptome of the ΔaraC mutant when exposed to oxidative stress and 
compared to that of F. tularensis LVS.  
We observed that the ΔaraC mutant was sensitive to several superoxide-generating 
compounds and peroxides. However, ΔaraC mutant did not exhibit any enhanced sensitivity 
towards superoxide-generating compound menadione (Figure 20). We chose menadione to 
induce the oxidative stress as this oxidant would not kill either the wild type or the mutant 
bacteria but would induce an oxidative stress response.  Wild type F. tularensis LVS and the 
ΔaraC mutant bacteria were either left untreated or treated with menadione (1.25 mM 
menadione) and incubated for 1 hour at 37οC. RNA was isolated and RNA sequencing was 
performed.  
Differential gene expression of F. tularensis LVS and the ΔaraC mutant was analyzed 
based on Log2(fold change) of the gene expression levels comparing the ΔaraC mutant to the 
wild type F. tularensis LVS and comparing menadione treated samples to the untreated. For 
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the downregulated genes, the expression of the araC gene which has been deleted in the ΔaraC 
mutant was taken as 100%. Any genes that represented less than 50% of the Log2(fold change) 
of the araC gene was considered as downregulated. However, to further narrow the number of 
genes identified as under the control of AraC, we considered the p-values and any value less 
than 0.05 was considered significant. All the data analyzed were cumulative of two 
independent experiments.  
 
4.5. Determination of  differentially expressed genes in the ΔaraC mutant  not exposed to 
oxidative stress  
At first, we identified differentially expressed genes in the ΔaraC mutant in comparison 
to the wild type F. tularensis LVS when bacteria were not exposed to oxidative stress. The 
Log2(fold change) of the araC gene in the ΔaraC mutant as compared to the wild type F. 
tularensis LVS was observed to be -0.67. Thus, 50% of this value (=-0.3) was used as a cut-
off to determine the downregulated genes in the ΔaraC mutant. The analysis showed that only 
the araC gene (FTL_0689) was significantly downregulated in the ΔaraC mutant not exposed 
to menadione. These results demonstrate that AraC is not required for gene regulation of F. 
tularensis under normal growth conditions. 
  
4.6. Determination of  differentially expressed genes in the ΔaraC mutant  exposed to 
oxidative stress 
Next, we identified the differentially expressed genes in the ΔaraC mutant as compared 
to the wild type LVS when the bacteria were exposed to oxidative stress. The lowest expression 
with a log2(fold change) of -1.08 was observed for the ΔaraC mutant. Based on this, we 
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selected a value of -0.5 or +0.5 Log2(fold change) as a cut-off to determine the differentially 
expressed genes in the ΔaraC mutant.  
 
4.6.1. Exposure of ΔaraC mutant to oxidative stress results in downregulation 
of genes encoded on Francisella Pathogenicity Island (FPI) 
 The RNA Sequencing results identified five downregulated genes encoded as an 
operon within the FPI. The expression of these genes remained unaltered when the ΔaraC 
mutant was not exposed to oxidative stress (Figure 23).  These genes encode factors of F. 
tularensis essential for intracellular survival and virulence [169]. The pdpC gene encodes a 
pathogenicity determinant protein that does not contribute to intracellular survival but is 
required for virulence in mice. On the other hand, pdpE is neither required for virulence nor 
intracellular survival. The iglJ gene product is required for intracellular growth, 
cytopathogenicity and virulence in mice, whereas iglI plays an important role in the 
phagosomal escape, cytopathogenicity, and virulence in mice [170]. The dotU gene product is 
an essential structural component of the Type VI secretion system (T6SS) of F. tularensis and 
is absolutely required for the functioning of T6S. Overall, these results indicate that AraC 





Figure 23. AraC regulates the expression of FPI genes when exposed to oxidative stress. 
A. Expression profile of FPI genes in the ΔaraC mutant upon exposure to menadione. The 
operon is indicated by the box. Data shown are from two independent experiments and 
expressed as Log2(fold change). B. The structure of T6SS. Modified from Clemens. D. L., 
Lee. B., Horwitz. M. A., 2018 [171] C. T6SS is required for the intracellular replication 
phase of F. tularensis indicated by red circle. Modified from Jones et al., 2012 [23]. 
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4.6.2. The ΔaraC mutant exhibits a dose-dependent attenuation of 
intramacrophage growth  
During its intracellular residence, F. tularensis is exposed to oxidative stress. We next 
verified if the downregulated FPI genes in the ΔaraC mutant when exposed to oxidative stress 
is associated with its impaired survival in macrophages. We used Raw macrophage cell line as 
host. We infected murine raw macrophages with the wild type F. tularensis LVS, the ΔaraC 
mutant, and the transcomplemented strain at 1, 10, 100, and 500  MOIs. The cells were lysed 
at 4 and 24 hours post-infection to determine the numbers of bacteria that invaded cells and 
replicated intracellularly. The results revealed that all the three Francisella strains invaded the 
macrophages with equal efficacy irrespective of the MOI used and identical bacterial numbers 
were recovered from all the three strains tested at 4 hours post-infection. At 24 hours, the 
differences were more prominent. At an MOI of 1, significantly less ΔaraC mutant bacteria  
(4.1±0.0 Log10 CFU/ml) were recovered from the infected macrophages as compared to the 
wild type strain (6.3±0.0 Log10 CFU/ml). Transcomplementation of the ΔaraC mutant partially 
restored the wild type phenotype (Figure 24A). At an MOI of 10 infection dose, there were 
fewer bacteria recovered from the macrophages infected with the ΔaraC mutant  (6.8±0.0 
Log10 CFU/ml) as compared to the wild type F. tularensis LVS (7.1±0.0 Log10 CFU/ml) 
(Figure 24B). Similar results were observed when the infection dose was increased to 100 
MOI with macrophages infected with the  ΔaraC mutant harbored significantly fewer bacteria 
(8.3±0.0 Log10 CFU/ml) than the wild type (8.5±0.0 Log10 CFU/ml) at 24 hours post-infection 
(Figure 24C).  At a saturating infection dose of 500 MOI, the difference in numbers of bacteria 
recovered from the ΔaraC mutant infected cells and the wild type F. tularensis infected 
macrophages was lost and equal numbers of bacteria were recovered from both groups of 
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infected macrophages (Figure 24D). Altogether, results from the macrophage assays 
demonstrate that ΔaraC mutant is attenuated for intramacrophage survival. The attenuation of 
intramacrophage growth of ΔaraC mutant is dose-dependent. These results also corroborate 
findings of the gene expression studies that AraC-dependent gene expression of the FPI genes 





   
 
 
Figure 24. The ΔaraC mutant is attenuated for intramacrophage survival.  Dose 
dependent attenuation of intramcarophage growth of ΔaraC mutant at an MOI: 1 (A), 10 
(B), 100 (C), and 500 (D). The data shown are cumulative of three independent experiments 
and are analysed using one way ANOVA. *** p<0.001; ** P<0.01. 
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4.6.3. The ΔaraC mutant exhibits attenuation of virulence in mice in a dose-
dependent manner 
To further establish that AraC-dependent regulation of FPI genes observed under 
oxidative stress is not only required for intramacrophage growth and survival, but also for 
virulence in mice, we performed in vivo experiments in a mouse model of tularemia.  We 
infected C57BL/6 mice intranasally with incremental doses (1x102, 1x103, 1x104, or 1x105 
CFUs) of F. tularensis LVS or the ΔaraC mutant and monitored their survival and body 
weights daily for 15 days (Figure 25). It was observed that the ΔaraC mutant was attenuated 
for virulence as compared to the wild type F. tularensis LVS. However, a dose-dependent 
increase in virulence of the ΔaraC mutant was observed. All of the mice infected with 1x102 
and 1x103 CFUs of the ΔaraC mutant survived the infection whereas 20% mice infected with 
1x102 CFUs and 40% of those infected with 1x103 of the wild type F. tularensis LVS 
succumbed to infection (Figures 25A and 25B, left panels). All mice infected with 1x104 and 
1x105 of F. tularensis LVS also succumbed to the infection by day 10.  However, 20% of mice 
infected with similar doses of the ΔaraC mutant survived the infection. All infected mice lost 
body weight during the first 3-6 days and then gradually regained their original body weight 
indicating that all mice received the infection. Collectively, these results demonstrate that AraC 
by regulating the FPI genes contributes to intramacrophage growth and virulence in mice in a 





Figure 25. The ΔaraC mutant exhibits a dose-dependent attenuation of virulence in 
mice: C57BL/6 mice inoculated with 1x102 (A), 1x103 (B), 1x104 (C), or 1x105 (D) CFU of 
F. tularensis LVS or the ΔaraC mutant intranasally. Survival and body weights of infected 
mice (n=5/group) were recorded for 15 days. The survival curves are plotted as Kaplan-
Meier survival curve (left panels). Body weights represented as Mean ±S.D. are shown in 
























4.6.4. Exposure of ΔaraC mutant to oxidative stress results in differential 
expression of stress response genes 
RNA Sequencing analysis also unveiled differential expression of another three genes, 
part of a stress response operon, in the ΔaraC mutant. Expression of these genes was 
significantly affected upon treatment with menadione. These three downregulated genes 
encode AroA, RnhA, and a hypothetical protein. rnhA gene (-0.48 Log2-fold change) encodes 
Ribonuclease H, which protects bacteria from killing by oxidative stress [172]. rnhA is a multi-
functional protein which is also actively involved in bacterial growth as simultaneous deletion 
of rnhA, rnhB, and rnhC leads to lethality in Bacillus subtilis [173]. The findings indicate that 
AraC could be involved in regulation of F. tularensis ribonuclease H abundance under 
oxidative stress (Figure 26A).  
Interestingly, another gene, rpoH, which encodes a sigma factor that shares homology 
with the σ32 heat-shock family, was also downregulated in the ΔaraC mutant irrespective of 
its exposure to oxidative stress [149]. RpoH modulates expression of several genes including 
stress response genes groEL/S, clpB, FTL_1957, dnaK, dnaJ, and hsp40 [174]. To investigate 
whether the absence of ΔaraC could change the expression profile of these heat shock proteins 
while exposed to oxidative stress, expression of groES, clpB, FTL_1957 dnaK, dnaJ, and 
hsp40 was determined by qRT-PCR. It was observed that expression of gorEL, dnaK, dnaJ 
and hsp40 genes that are primarily involved in heat-shock response was significantly 
upregulated in the ΔaraC mutant.  Collectively, these results indicate that AraC serves to 
positively regulate the expression of rpoH which in-turn negatively regulates the expression of 
heat-shock proteins (Figure 26B).  
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Further, to verify the participation of AraC in regulating heat-shock response, we 
conducted thermal resistance experiment in which bacteria were exposed to a high temperature 
(48οC), higher than the homeostatic temperature (37οC). The transcomplemented strain was 
utilized as a positive control because araC in the transcomplemented vector is under the control 
of GroEL promotor, activated at high temperature. Figure 26C shows that the viabilities of all 
these three Francisella strains were not affected when exposed to a temperature of 37οC for 1 
hour. The findings indicate that at the physiological temperature, AraC exerts no benefit or 
hindrance to F. tularensis growth.  
Next, we induced high-temperature stress by growing the bacteria at 48οC (Figure 
26D). At the start point, the CFU/ml for these three Francisella strains were set approximately 
equal. After 1 hour of incubation, these three strains exhibited a significant decrease in the 
viable bacterial count. The numbers of the ΔaraC mutant bacteria (7.8±0.0 Log10CFU/ml) 
were significantly higher than the wild type F. tularensis LVS (7.5±0.0 Log10CFU/mL). The 
transcomplemented strain survived better than the former two Francisella strains tested, with 
significantly higher numbers of bacteria (8.3±0.0 Log10CFU/mL) survived at the higher 
temperature. Overall, the results indicate that AraC of F. tularensis LVS regulates the 
expression of heat-shock proteins negatively and facilitates its survival under extreme stress 
conditions.  
In addition to the aforementioned, aroA gene (-0.55 Log2-fold change) was also 
downregulated in ΔaraC mutant in response to oxidative stress. aroA encodes 3-
phosphoshikimate 1-carboxy-acyltransferase, which is an enzyme required in the shikimate 
pathway responsible for the bio-synthesis of enolpyruvyl shikimate-3-phosphate, inorganic 
phosphate, folate, and aromatic amino acids [175] (Figure 26E). This pathway is important 
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for bacterial metabolism and homeostasis [175]. The finding that downregulation of the aroA 
RNA abundance in ΔaraC mutant after treatment with menadione implied that AraC is 






Figure 26. AraC regulates stress response genes of F. tularensis LVS. (A) Expression 
profile of genes involved in heat and stress response in the ΔaraC mutant as compared to 
the wild type F. tularensis LVS untreated or treated with menadione. Data are cumulative 
of 2 independent experiments (B) qRT-PCR analysis of indicated heat-shock proteins in the 
ΔaraC mutant and the wild type F. tularensis LVS treated with menadione. The data shown 
are cumulative of three independent experiments. Data were analyzed using Two-tailed 
student T-test. (C) CFU of the ΔaraC mutant, the wild type F. tularensis LVS, and the 
transcomplemented strain on exposure to 37οC versus 48οC for I hour (D). (E) The shikimate 
pathway required for aromatic amino acid synthesis showing the involvement of aroA gene 
in the sixth step. Modified from Lutke-Eversloh, T. & Stephanopoulos. G., 2005 [176]. The 
results are cumulative of three independent experiments. The data were analyzed using one 




4.6.5. Genes responsible for energy production during oxidative stress  are 
differentially regulated in the araC mutant 
In addition to FPI and heat-shock proteins, RNA sequencing identified a set of genes 
responsible for the production of ATPases that were downregulated in the ΔaraC mutant in 
the presence of oxidative stress (Figure 27A). These genes transcribed on a single operon are 
required for catalysis, synthesis, and hydrolysis of ATP [177]. They are also part of trans-
membrane proton (H+) translocator in prokaryotes [178]. ATP synthases are composed of two 
molecules: F0 is attached to the periplasmic membrane and F1 extends to the cytoplasmic space 
and forms the catalytic region of the enzyme [177] (Figure 27B). RNA Sequencing analysis 
revealed downregulation of ATP synthase subunits, except A subunit of F0 was upregulated in 
the ΔaraC mutant post-exposure to menadione. Three of the genes affected to the greatest 
extent were those encoding ATP synthase subunits of F1 molecule: γ, β, and AtpC (ε).  
Altogether, these results demonstrate that AraC of F. tularensis differentially regulate the 






Figure 27. AraC differentially regulates the expression of genes involved in energy 
production during oxidative stress. (A) Gene expression profile shows differentially 
expressed ATP synthase genes in the ΔaraC mutant in the normal versus oxidative stress 
conditions. The data are derived from two independent experiments. (B) Illustration of the 
ATPase structure showing the main two molecules F0 and F1 and their subunits. Modified 





4.6.6. AraC of F. tularensis positively regulates key components of TCA cycle 
during oxidative stress  
Exposure of the ΔaraC mutant to menadione downregulated expression of genes 
involved in metabolism encoded on four different operons. One of these genes encodes the 
enzyme pyruvate dehydrogenase subunits: E1, E2, and E3, required for the biosynthesis of 
Acetyl-CoA, an enzyme that initiates the TCA cycle [180]. Among the three subunits, E3 or 
dihydrolipoyl dehydrogenase encoded by lpd was downregulated in the ΔaraC mutant exposed 
to oxidative stress as compared to the wild type F. tularensis LVS. The other two subunits, E1 
pyruvate dehydrogenase (AceE) and E2 digydrolipoyl transacetylase (AceF), were also 
downregulated in the ΔaraC mutant. The results demonstrate that AraC activates the TCA 
cycle in F. tularensis under oxidative stress (Figure 28).  
The expression of genes encoded on another operon was downregulated in the ΔaraC 
mutant. This operon comprised of the genes required for the biosynthesis of pantothenate 
(vitamin B5), which is the central component of coenzyme-A [181]. The RNA Sequencing data 
analysis revealed that coaX gene encoding type III pantothenate kinase was downregulated in 
the ΔaraC mutant as compared to the wild type when subjected to oxidative stress. The analysis 
also exhibited downregulation of aspartate-1-decarboxylase panD gene, required for the 
formation of β-alanine from L-aspartate [182],  the panC gene encoding the pantothenate 
synthase that employs β-alanine and L-pantoate for the production of pantothenate [183]. The 
expression levels of panB (ketopantoate hydroxymethyltransferase) and panG (ketopantoate 
reductase) were also downregulated in menadione treated ΔaraC mutant as compared to the 
wild type F. tularensis LVS. Enzymes, PanB and PanG, catalyze the conversion of 2-
oxoisovalerate to 2-dehydropantoate and pantoate, respectively [182]. Altogether, these results 
90 
 
indicate that, under oxidative stress, AraC of F. tularensis positively activates the pantothenate 
biosynthesis pathway that is required for coenzyme-A formation to initiate the TCA cycle [181, 
184].  
Furthermore, exposing ΔaraC mutant to oxidative stress altered the expression of genes 
encoded on an additional metabolic operon. This operon harbors three genes; pgk, pyk, and 
fba. The pgk gene encodes phosphoglycerate kinase, an enzyme that catalyzes the formation 
of ATP from ADP [185]. The  pyk gene, encoding for pyruvate kinase [186], which is involved 
in the production of ATP and pyruvate, crucial for several metabolic pathways including the 
TCA cycle [186]. Moreover, the fba gene was downregulated to a greater extent in the ΔaraC 
mutant post-exposure to menadione. This gene encodes fructose-bisphosphate aldolase class 
II (FBA), which is required for the formation of fructose 1,6-bisphosphate (FBP) through the 
gluconeogenesis and glycolysis pathways in Francisella. [187]. FBA is required for bacterial 
virulence and is essential for intracellular survival, indicating the significance of these 
metabolic pathways in bacterial pathogenesis [187]. Thus, downregulation of this operon 
suggests that AraC of F. tularensis positively regulates glucose metabolic pathways in addition 
to the TCA cycle during oxidative stress to sustain intracellular survival of F. tularensis. 
In addition to the genes above, RNA expression levels of a set of metabolic genes were 
changed in the ΔaraC mutant when treated with menadione. This operon encodes key enzymes 
that are implicated in the TCA cycle. The two most downregulated genes were sucA and sucB 
encoding oxoglutarate dehydrogenase subunits E1 and E2, respectively. This enzyme catalyzes 
the transformation of 2-oxoglutarate into succinyl-CoA in the TCA cycle [188] and reduction 
in the RNA expression level of these genes indicate that oxoglutarate dehydrogenase activity 
of F. tularensis is deactivated in the ΔaraC mutant during oxidative stress. Furthermore, the 
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genes, tpiA, glmM, and apt, encoding triosephosphate isomerase, phosphoglucosamine mutase 
and adenine phosphoribosyltransferase required for gluconeogenesis pathway, were all 
downregulated in the ΔaraC mutant during oxidative stress. The remaining genes within the 
operon were impacted to a lower extent in the ΔaraC mutant, upon treatment with menadione, 
including secG that codes for the preprotein translocase subunit SecG and genes that code for 
the succinate dehydrogenase enzyme contributing to the TCA cycle and oxidative 
phosphorylation pathway [189, 190]. Succinate dehydrogenase is composed of 4 subunits: 
SdhA, SdhB, SdhC, and SdhD, and their expression remained unaltered in the ΔaraC mutant 
as compared to the wild type (Figure 28).  
Collectively, the RNA sequencing data analysis indicate that inducing oxidative stress 
in the ΔaraC mutant diminishes the expression of various genes encoding key elements of the 
metabolic pathways; TCA, and electron transport channels. Thus, AraC as a transcriptional 
regulator plays a significant regulatory role in the metabolism of F. tularensis required for 





Figure 28. AraC is involved in the regulation of genes encoding key metabolic enzymes. 
(A) Gene expression profile of the ΔaraC mutant as compared to the wild type F. tularensis 
LVS of genes encoded on four operons  (operons labeled by blue boxes). Genes prodcut 
composing TCA cycle key enzymes are labled by blue parenthesis to the right. The Log2(fold 
change) values are indicated. The data represent the average of gene expression from two 
independent experiments. (B) Pathway of glucose metabloism ending in TCA cycle. 
Enzymes downregulated by ΔaraC mutant during oxidative stress are highlited in red. 






4.6.7. AraC-dependent transcription of regulatory proteins  
     We identified an additional set of genes encoded on operons that were differentially 
expressed in the ΔaraC mutant as compared to the wild type F. tularensis LVS after 
induction of oxidative stress (Figure 29A). One of the operons is composed of genes 
encoding: trkA, amino acid antiporter, and a hypothetical protein that was downregulated to 
a great extent when the ΔaraC mutant was exposed to the oxidative stress. The trkA gene 
encodes a potassium uptake protein. Moreover, the expression level of two genes: rpoB and 
rpoC, on another operon was significantly downregulated in the menadione treated ΔaraC 
mutant. These genes encode two of the RNA polymerase core proteins: the β (RpoB) and β’ 
(RpoC) subunits [149] (Figure 29B), indicating that AraC is also involved in regulating F. 
tularensis transcriptional process during oxidative stress. Another gene (FTL_1051) that 
encodes NAD(P)/FAD-dependent oxidoreductase was upregulated in the  ΔaraC mutant as 
compared to the wild type F. tularensis LVS. This enzyme is known to catalyze the redox 
reactions of nicotinamide adenine dinucleotide NAD(P)H or NAD(P)+ [192]. However, no 
studies have done to determine the role of this enzyme in F. tularensis during oxidative 
stress. Altogether, these results indicate that AraC of F. tularensis displays a regulatory effect 
on the structural components of RNA polymerase and gene products involved in the redox 





Figure 29. AraC-dependent transcription of regulatory proteins. (A) Gene expression 
profile of regulatory genes within four operons of the ΔaraC mutant. (operons labeled by 
blue boxes to the right). The Log2(fold change) values are indicated. Data presented are 
cumulative of two independent experiments. (B) RNA polymerase Holoenzyme structure 
modifed from Johnson Chavarria, E.M., 2016 [193]. The structure is composed of five 
molecules and sigma factor to initiate RNA synthesis. Red circles indicate core subunits (β 
and β’) encoded by rpoB and rpoC, respectively, and are downregulated by ΔaraC mutant 
in response to oxidative stress. 
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4.6.8. Transcriptional units differentially regulated by AraC of F. tularensis  
Apart from regulating the RNA expression levels of genes encoded on operons, AraC 
of F. tularensis exhibited a significant regulatory effect on a few transcriptional units during 
oxidative stress. Figure 30 represents the differentially expressed genes in the ΔaraC 
mutant as compared to the wild type F. tularensis LVS. The araC gene which is transcribed 
as a single transcription unit remained downregulated to the greatest extent irrespective of 
the treatment with menadione in the ΔaraC mutant.  The pyrH gene that encodes uridylate 
kinase enzyme to catalyze the synthesis of pyrimidine was also downregulated [194], 
suggesting that AraC is involved in nucleotide damage repair in response to oxidative stress. 
Another gene in the ΔaraC mutant that was largely affected by menadione treatment was 
FTL_0426 coding for type I DNA topoisomerase. This enzyme is required for DNA 
supercoil repair [195], indicating that AraC is also involved in the regulation of DNA repair 
mechanisms in F. tularensis during oxidative stress. Furthermore, two genes FTL_0024 and 
FTL_0031 were significantly upregulated in ΔaraC mutant compared to the wild type. 
These genes encode serine/threonine transporter and acid phosphatase, respectively, 
indicating that AraC negatively regulates genes required for transport of amino acids (serine 
and threonine) during the conditions of oxidative stress. Additionally, since acid 
phosphatase is essential for glucose and G6P phosphorylation and dephosphorylation 
mechanisms in bacteria [196], AraC of F. tularensis is possibly involved in the negative 





Figure 30. Transcriptional units differentially regulated by AraC of F. tularensis. Gene 
expression profile displaying the genes transcribed as single transcription units that are 
regulated by AraC. The Log2(fold change) values are indicated. The data represent the 





FTL_0426 -0.07 -0.51 type I DNA topoisomerase
FTL_0662 -0.25 -0.64 helix-turn-helix domain-containing protein
FTL_0689 -0.67 -1.08 araC
FTL_1297 -0.3 -0.56 hypothetical protein
FTL_0024 0.24 0.53 serine/threonine transporter




  As a Tier 1 Select Agent, F. tularensis has a high infectivity rate and rapid onset of the 
disease known as tularemia [19]. Many studies have devoted enormous efforts to understand 
how F. tularensis avoids host defense mechanisms, replicates within an extremely secure 
immune system, and eventually causes the deadly disease tularemia. Understanding virulence 
mechanisms of F. tularensis is a fundamental approach that will certainly assist in decoding 
the pathogenesis and navigating to the proper development of tularemia vaccine and 
therapeutics. Furthermore, the ability of F. tularensis to survive the host bactericidal 
mechanisms and replicate intracellularly is attributed to its unique regulation of virulence 
genes. Gene regulation of F. tularensis virulence is complicated and is adaptable to the accurate 
detection of environmental stimuli and host response to infection [137, 197]. Also, gene 
regulation employs regulatory molecules and transcriptional regulators that dictate the 
differential gene expression [197]. Transcriptional regulators are categorized based on their 
structure, function, sequence conservation of DNA binding motifs, and amino acids alignment 
[119, 197].  
 The AraC/XylS family is one of the largest families of bacterial transcriptional regulators 
[139, 197]. Members of the AraC/XylS family can alter gene expression, mostly, positively 
[119, 139, 197]. In rare cases, gene expression can be either negatively altered by members of 
the family such as the CelD of Y. pestis [198], or both positively and negatively by the AraC 
of E. coli and YbtA of Y. pestis [139, 199]. Transcriptional regulators are additionally classified 
into two categories based on the regulation of their own transcription [139]. The first category 
has signal receptors within the same protein that respond to the availability of substrates to 
activate or repress genes expression [139]. Examples of this type of transcriptional regulators 
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are AraC, XylS, RhaR, and UreR [139, 157, 200-202]. The second category requires the 
activity of another regulator (activator or repressor) to control gene expression in a two-
component regulatory system manner such as MarA, SoxS, and TcpN [120, 139, 203, 204]. 
The AraC/XylS family proteins operate three unique features, which are regulation of virulence 
factors, stress response, and metabolism of carbons [139].   
  In the present study, we have characterized the role of a transcriptional regulator; AraC, 
a member of the AraC/Xyls family, in intramacrophage survival and virulence of F. tularensis. 
To date, no study has been conducted characterizing the regulatory role of AraC in Francisella. 
Thus, the findings from this study are novel. Sequence alignment with previously characterized 
AraC/XylS family proteins confirmed the presence of the unique HTH DNA binding domain 
in the C-terminal residues of AraC. This signature DNA binding motif is conserved in all 
members of the AraC/XylS family [139, 205]. The FTL_0689 gene encodes AraC of F. 
tularensis LVS.  
  In this study, we considered several aspects for the investigation of the role of AraC 
transcriptional regulator in tularemia pathogenesis. First, AraC is an extensively studied 
transcriptional regulator in E. coli that is involved in the metabolism of  L-arabinose [139, 197, 
206]. Since L-arabinose metabolism has never been studied in F. tularensis, we considered 
investigating this phenotype. Second, the araC gene of F.tularensis is located upstream of the 
operon encoding Emr type MEP and transcribed in a divergent direction. Given the fact that 
most AraC/XylS family regulators are transcribed divergently from their target gene or operon 
[205], and since we have previously reported the involvement of MEP components, the emrA1 
and silC, in F. tularensis virulence [87, 112], we hypothesized that araC of F. tularensis LVS 
regulates the expression of the MEP components. Third, members of the AraC/XylS family 
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such as AraC of E. coli and YbtA of Y. pestis had been reported to exert their regulation in cis 
or in trans [139, 199], proposing a possibility for AraC to regulate F. tularensis genes in trans. 
Given the rationales above, we hypothesized that AraC of F. tularensis is a unique 
transcriptional regulator that plays an important role in tularemia pathogenesis. An AraC gene 
deletion mutant was generated in this study and characterized phenotypically with regards to 
L-arabinose utilization, sensitivity to oxidants, heavy metal ions, and antibiotics.  Further, we 
investigated the global gene regulation of AraC in F. tularensis LVS in response to oxidative 
stress. 
  Results from sugar utilization experiments unveiled that AraC transcriptional regulator 
is not involved in L-arabinose utilization as F. tularensis LVS is deficient for growth in the 
presence of L-arabinose.  It also highlighted that the availability of D-glucose is indispensable 
for the growth of F. tularensis LVS and is the sugar source of choice. These findings 
demonstrate that unlike the AraC transcriptional regulator of E. coli involved primarily in L-
arabinose metabolism, the AraC of F. tularensis LVS has a distinct function other than the 
carbon metabolism.  
  The genomic organization of the Emr type multidrug efflux pump (MEP) of F. tularensis 
is unique, composing of three adjacent genes emrB, emrA1, and silC that constitute an operon 
[87, 112]. The transcription of the araC gene in the opposite direction of emrB, emrA1, and 
silC genes suggested a possible involvement of AraC in the regulation of these MEP genes. A 
similar genomic structure of MEP is present in Pseudomonas aeruginosa (P. aeruginosa) with 
MexR transcriptional regulator transcribed divergently from the mexAB-oprM multidrug efflux 
system [118]. In response to oxidative stress, MexR transcriptional regulator detaches from the 
promotor and functions as an activator to initiate the MEP genes expression [118]. Moreover, 
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Campylobacter jejuni (C. jejuni) possesses a cmeGH multidrug efflux pump that is controlled 
by Fur repressor transcribed divergently upstream of the operon [116]. Therefore, as a 
transcriptional regulator, araC was hypothesized to control the expression of the components 
of the MEP. This notion was investigated by using emrA1 mutant as a comparison tool 
throughout this study and supported by results from qRT-PCR analysis that MEP components 
are downregulated in the ΔaraC mutant in response to oxidative stress, suggesting a possible 
role for AraC in MEP gene regulation.  
  Oxidant sensitivity testing was performed using peroxides and superoxide-generating 
compounds. Results from peroxides sensitivity testing demonstrated that similarly to the 
emrA1 mutant, the ΔaraC mutant is sensitive to increasing concentrations of H2O2. 
Additionally, the ΔaraC mutant exhibited high sensitivity to organic peroxides as compared to 
the wild type F. tularensis LVS. A similar phenotype has also been reported for the emrA1 and 
silC mutants of F. tularensis LVS [87, 112]. On the other hand, results from the sensitivity 
testing of superoxide-generating compounds revealed an enhanced sensitivity of the ΔaraC 
mutant towards pyrogallol but not against paraquat or menadione. Studies on emrA1 and silC 
mutants have demonstrated a high sensitivity to these superoxide-generating compounds [87, 
112].  
  The selective sensitivity of ΔaraC mutant to one superoxide-generating compound but 
not to others can be attributed to the mechanism of action of each compound. Paraquat is a 
redox cycling compound that disrupts the electron transport channel in the bacterial cell 
membrane by inhibiting the reduction of NADP to NADPH during the redox reactions 
resulting in the production of highly microbicidal reactive oxygen species (ROS) such as 
superoxide anion, singlet oxygen, hydroxyl, and peroxyl radicals [207, 208]. Menadione is a 
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redox-cycling compound that induces oxidative stress in bacteria by acting first as 
aminoglycoside to disrupt the cell wall and plasma membrane [209] and then transporting into 
the bacterial cell where it converts molecular oxygen into superoxide radicals and H2O2 as a 
result of reduction by redox enzymes [210]. Both the compounds act by disrupting the bacterial 
plasma membrane to induce the production of ROS. However, several factors can induce the 
resistance of ΔaraC mutant to both paraquat and menadione. One of them is the presence of 
the outer membrane that inhibits the permeability of these superoxide-generating compounds 
into the cytoplasmic membrane of the bacteria [211]. In addition, F. tularensis produces the 
antioxidant enzymes, SodB and SodC, that maintain the redox homeostasis and hinder the 
production of ROS [30]. Since ΔaraC mutant did not exhibit enhanced sensitivity toward 
paraquat and menadione, we perceived that the production of the antioxidant enzymes is not 
disrupted by the araC gene deletion. Secretion of SodB and KatG enzymes is impaired in the 
emrA1 mutant [87, 112].  Thus, AraC due to its impact on the expression of the MEP genes 
may lower the secretion of these antioxidant enzymes but may not completely abolish it and 
therefore mirror the phenotype of the emrA1 mutant.   
  Furthermore, pyrogallol, a polyphenolic compound with an antibacterial effect reported 
on a wide range of Gram-negative as well as Gram-positive bacteria [212-215]. Pyrogallol is 
a type of catechins that kills bacteria by interaction with the cytoplasmic membrane, resulting 
in disruption of membrane permeability [215, 216]. In a study conducted on epigallocatechin 
gallate mechanism of action on Bacillus subtilis demonstrated that this compound attaches to 
and disrupts the outer membrane proteins, including transport systems of the bacteria, and then 
generates H2O2 and cerium [216] that consequently leads to ROS production. Another study 
also demonstrated that epigallocatechin gallate attaches to the porin protein in the outer 
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membrane of E. coli to diminish its activity [217]. The sensitivity of ΔaraC mutant to 
pyrogallol as compared to the wild type suggests that ΔaraC mutant may have encountered 
membrane protein damage. We speculate that AraC may be important for maintaining 
membrane integrity of F. tularensis through the regulation of genes involved in this function. 
Since the emrA1 and silC mutants exhibited extreme sensitivity to pyrogallol [87, 112], and 
as we indicated previously that members of the AraC XylS family function in a two-component 
regulatory manner [139], we proposed that AraC may participate in MEP components 
regulation.    
  The results from this study demonstrated that AraC of F. tularensis is not involved in 
resistance to heavy metals. Similar to the wild type F. tularensis LVS, ΔaraC mutant was not 
sensitive to treatment with silver nitrate. Resistance to silver compounds had been proposed to 
be inherited among different Francisella species [87]. Silver nanoparticles used as an 
antibacterial cure for various fish infections are not effective in treating cases of Francisella 
noatunensis [218]. In contrary to ΔaraC mutant, studies on heavy metals sensitivity unveiled 
that emrA1 and silC mutants are extensively sensitive to silver compounds [87, 112]. This 
indicated that MEP components of F. tularensis are required for heavy metal resistance but 
AraC does not contribute to this resistnace.  
   Furthermore, the results from this study revealed that AraC of F. tularensis is not 
involved in antibiotic resistance. Antibiotic susceptibility testing against various classes of 
antibiotics unveiled that ΔaraC mutant is identical to the wild type F. tularensis LVS in 
antibiotic sensitivity.  In contrary, EmrA1 and SilC together were reported to be responsible 
for the effusion of some antibiotic subsets including streptomycin, nalidixic acid, and 
chloramphenicol [87]. Additionally, transcriptional regulators of other bacterial species 
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including AarP (Providencia stuartii), MarA and Rob (E. coli), and RamA (Klebsiella 
pneumoniae) are involved in regulation in regards to antibiotics, organic compounds, and 
heavy metals stressors [139, 219, 220]. Altogether, we concluded that AraC transcriptional 
regulator of F. tularensis does not directly contribute to the regulation of MEP genes. 
  Phenotypic characterization of ΔaraC mutant suggested that AraC transcriptional 
regulator of F. tularensis may be involved in the regulation of the oxidative stress response. 
Therefore, investigation of the global regulatory role of AraC of F. tularensis was performed 
to obtain novel understanding about its role in response to oxidants. The results from whole 
transcriptome data analysis in the absence of oxidant stressor revealed that despite the loss of 
araC gene in the mutant, the transcription profiles of both the ΔaraC mutant and the wild type 
F. tularensis LVS were identical. These results demonstrated that AraC transcriptional 
regulator of F. tularensis does not exert its regulatory role when bacteria are growing in rich 
homeostatic growth conditions. These results also suggested that AraC gets activated only 
when the bacteria are exposed to certain stress conditions. Since the ΔaraC mutant exhibited 
sensitivity towards oxidants, our primary hypothesis was that AraC plays a regulatory role 
under the conditions of oxidative stress. SoxS, an AraC/XylS family transcriptional regulator 
of E. coli is induced by oxidative compounds including paraquat and menadione to activate 
the transcription of the SoxRS regulon  [120, 139, 204]. 
  Our results demonstrate that activation of the AraC transcriptional regulator of F. 
tularensis in response to oxidative stress induced by menadione resulted in the differential 
expression of a multitude of genes some of which are transcriptional units and/or co-
transcribed as operons. These genes are involved in key pathways that contribute to tularemia 
pathogenesis. Whole transcriptome analysis of bacteria treated with menadione confirmed the 
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notion that AraC transcriptional regulator requires to be induced by a stressor to employ its 
regulation. The results from this study unveiled the involvement of AraC in the positive 
regulation of some FPI genes in response to oxidative stress. Components of the FPI were 
determined to constitute a Type VI secretion system of F. tularensis [221]. We demonstrated 
that ΔaraC mutant treated with menadione exhibited a significant downregulation of a subset 
of FPI genes. Thus far, several studies have published the fundamental role of FPI genes in 
intramacrophage replication and/or Francisella virulence [102, 222-225]. In F. novicida, iglJ, 
iglI, and iglG were found to be crucial for Type VI secretion system assembly [226].  We 
observed that iglJ and iglI genes were significantly downregulated in ΔaraC mutant following 
menadione treatment, indicating that type VI secretion system assembly may be impaired in 
the mutant. The FPI genes iglJ, iglI, or iglG however, have been reported to be indispensable 
for intramacrophage replication and, specifically, the phagosomal escape [226].  
  Our results demonstrated the downregulation of dotU gene in the ΔaraC mutant. DotU 
is one of the Type VI secretion system core proteins [170]. In Legionella pneumophila, IcmF-
DotU homologs are required for Type IV secretion system stability but not for its functionality 
[227]. However, DotU is crucial for type VI secretion system functionality in F. tularensis 
[170].  DotU protein is implicated in the secretion of other FPI proteins: Hcp and VgrG of 
Vibrio cholerae and P. aeruginosa [101]. In F. tularensis, DotU is an essential virulence factor 
required for intracellular growth and virulence in mice [170]. Furthermore, the results 
exhibited a significant reduction in pdpC gene expression of ΔaraC mutant in response to the 
oxidant. While PdpC in conjugation with PdPD were found to be partially involved in 
intramacrophage growth of F. novicida and Schu S4, they are extensively required for the 
complete virulence in vivo [228, 229].  
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  The results also revealed the downregulation of pdpE and Hcp genes in ΔaraC mutant 
after exposure to menadione. It was reported that PdpE structure and full functionality is 
affected by pdpC gene integrity [228]. A defect in pdpC gene results in the transcription of a 
disrupted PdpE protein. Similarly, the downregulation of pdpE gene in ΔaraC mutant can be 
caused either by exposure to menadione or due to the downregulation of the pdpC gene. 
Another study also published the possibility of the presence of a sec secretion signals in PdpE 
due to its ability to translocate into the outer membrane of Francisella [170]. In an attempt to 
define the role of PdpE in F. tularensis, it was demonstrated that PdpE protein sequence 
exhibited poor homology with the Hcp protein. However, both proteins were found to perform 
distinct functions [170]. While pdpE is dispensable for type VI secretion system assembly, 
phagosomal escape, or virulence in mice in both of the F. novicida [226] and F. tularensis LVS 
[230], its role is yet to be determined. The Hcp protein, on the other hand, is one of type VI 
secretion system major structural proteins [231]. It forms a tube-like channel in F. tualrensis 
that is in conjunction with VipA and VipB sheathing to facilitate the translocation of a principle 
virulence protein, VgrG, effector domain into its target location [170].  The downregulated 
gene expression profile of the FPI genes in the ΔaraC mutant, also corroborates with attanuated 
intramacrophage survival and virulence of F. tularensis in mice in a dose-dependent manner.  
  Besides the FPI encoded genes, the whole transcriptome analysis of the ΔaraC mutant 
under oxidative stress also revealed the involvement of AraC of F. tularensis LVS in the 
regulation of two genes, aroA, and rnhA, that are a part of heat stress related operon. The role 
of AroA in Francisella is not determined yet. However, in Salmonella, AroA is involved in 
the shikimate pathway that catalyzes the synthesis of aromatic amino acids from glucose [232]. 
Attenuation of the aroA gene, commonly used to study metabolic pathways, results in 
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accumulation of pyruvate within the bacteria and consequently cause osmotic pressure [233]. 
Therefore, AroA is essential to maintain bacterial homeostasis through the shikimate pathway. 
In addition, it was reported that aroA gene deletion of Salmonella resulted in aromatic amino 
acids auxotrophy and attenuation of virulence [232].  In agreement with the role of AroA in 
Salmonella, oxidative stress resulted in the downregulation of aroA gene in the ΔaraC mutant 
that can further explain the attenuation of intramacrophage growth and virulence in mice.  
  AraC of F. tularensis positively regulated the rnhA gene that encodes ribonuclease H. In 
many Gram-negative bacteria such as Yersinia, Salmonella, Helicobacter pylori (H. pylori), 
and Shigella flexneri, ribonucleases are known to function as virulent factors [234]. A study 
reported that RnhA contributes to Mycobacterium smegmatis (M. smegmatis) defense against 
the destruction by oxidative stress [172]. In the same study, it was reported that deletion of 
rnhA gene has no impact on the bacterial viability [172]. Interestingly, deletion of both rnhA 
and rnhB genes in M. smegmatis enhanced bacterial sensitivity to H2O2 [172], which explains 
the sensitivity of the ΔaraC mutant to H2O2 observed in this study. Other studies also 
demonstrated that rnhA in conjugation with rnhB and rnhC genes are required for B. subtilis 
viability [173]. Therefore, we propose that AraC by regulating the epression of rnhA gene 
protects F. tularensis against oxidative stress. 
  In addition, we have observed that the expression level of rpoH gene was not altered in 
ΔaraC mutant in response to oxidative stress and remained downregulated. However, results 
from qRT-PCR unveiled the significant upregulation of heat shock proteins (GroEL, DnaK, 
DnaJ, and Hsp 40) in the ΔaraC mutant after menadione treatment. In E. coli, GroES and 
GroEL proteins were discovered to be induced in response to various stressors including heat 
shock, oxidative stress, nutrient deprivation, and SOS [235]. Additionally, DnaK protein was 
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also detected when exposing bacteria to peroxides, UV radiation, nutrient deprivation, and 
some antimicrobial agents [235]. Similarly, a study on F. tularensis reported that RpoH is 
required for the positive regulation of heat shock proteins when bacteria are under different 
stress conditions including high temperature or oxidative stress [149]. Therefore, although heat 
shock proteins are mostly induced in response to high-temperature stress, other stressors also 
promote their induction. We confirmed this notion as well as the role of AraC in regulating 
heat shock genes by conducting a thermal resistance experiment. The result demonstrated that 
in the physiologic temperature, the growth of ΔaraC mutant is similar to the wild type strain. 
However, when growing the bacteria in extremely high temperature, the ΔaraC mutant 
exhibited significantly enhanced viability as compared to the wild type F. tularensis LVS. The 
viability of the transcomplemented strain was significantly higher than both the ΔaraC mutant 
and the wild type F. tularensis LVS the due to the presence of the GroEL promotor in the 
transcomplementation vector that governs the expression of araC. These findings support our 
qRT-PCR results and demonstrate that AraC is required for the regulation of heat shock 
proteins in F. tularensis in response to heat and oxidative stresses. 
  The results from whole transcriptome analysis further highlighted the involvement of 
AraC of F. tularensis LVS in the positive regulation of F1F0 ATP synthases in response to 
oxidative stress. Treatment with menadione induced the significant downregulation of the 
ATPase subunits in ΔaraC mutant as compared to the wild type F. tularensis LVS. ATPases 
are known for their role in the generation of the electrochemical gradient to facilitate the 
penetration of protons, ions, and metabolic molecules through cell membrane [236, 237]. 
ATPases are required by pathogens to tolerate acidic environments. In Streptococcus mutans, 
ATPase gene is upregulated when the bacteria is under acidic pH stress [238]. Additionally, 
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ATPases are crucial for energy conveyance in several pathogens. ATPases catalyze the 
conversion of ADP and inorganic phosphate into ATP [239].  Few studies have also reported 
the response of the ATPases during oxidative stress. In E. coli, YchF protein has an ATPase 
activity that is sensitive to H2O2 exposure. It was reported that OxyR transcriptional regulator 
causes the downregulation of ychF in response to oxidative stress [240]. The downregulation 
of ATPases in the ΔaraC mutant in response to oxidative stress indicates that AraC stimulates 
ATPases to support oxidant resistance. The results allow us to speculate that oxidative stress 
inhibits energy production in the ΔaraC mutant, and consequently impeds other vital 
mechanisms. 
  The results from this study further demonstrated the engagement of AraC in the 
regulation of the TCA cycle in F. tularensis during oxidative stress. Several studies have linked 
the TCA cycle with the virulence of F. tularensis during stress conditions [187, 188, 241, 242]. 
We observed the downregulated gene expression of key TCA cycle enzymes in the ΔaraC 
mutant after menadione treatment. The operon encoding pyruvate dehydrogenase enzyme was 
significantly downregulated. The pyruvate dehydrogenase is an enzyme that catalyzes the 
synthesis of the first enzyme, Acetyl-CoA, of the TCA cycle  [180]. It has three subunits: E1: 
pyruvate dehydrogenase (AceE), E2: dihydrolipoamide transacetylase (AceF), and E3: 
dihydrolipoamide dehydrogenase (Lpd) [188]. We also observed downregulation of another 
enzyme, oxoglutarate dehydrogenase, encoded on another operon. The oxoglutarate 
dehydrogenase promotes the conversion of α-ketoglutarate (or 2-oxoglutarate) into succinyl-
CoA in the TCA cycle. Oxoglutarate dehydrogenase is also composed of three subunits: E1: 
2-oxoglutarate dehydrogenase (SucA), E2: dihydrolipoamide succinyltransferase (SucB), and 
E3: lipoamide dehydrogenase (Lpd) [188]. In F. novicida, a study had shown the requirement 
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of the E1(AceE) subunit of the pyruvate dehydrogenase enzyme in intramacrophage growth 
[243]. In addition, another study have demonstrated the contribution of E3 (Lpd) subunit to F. 
tularensis LVS virulence [148]. Other than its major role in metabolism, the E3 (Lpd) subunit 
is a component of M. tuberculosis defense mechanism against oxidative stress [244]. 
Furthermore, double deletion of sucA and suB genes in S. Typhimurium attenuated the bacteria 
for virulence in mice [245]. In accordance with the results from studies explained above, 
exposing AraC deficient bacteria to the oxidant repressed the expression of all three subunits 
both pyruvate dehydrogenase and oxoglutarate dehydrogenase. Moreover, we have observed 
that ΔaraC mutant is attenuated for intramacrophage growth and virulence in mice. Therefore, 
it appears that regulation of the TCA cycle of F. tularensis LVS by AraC is also associated 
with intramacrophage survival and virulence especially when the bacteria are experiencing an 
oxidative stress environment.  
  The results from whole transcriptome analysis denoted that AraC regulates the 
pantothenate metabolism in F. tularensis. The pantothenate, also known as vitamin B5, is an 
essential metabolic molecule that is a central component of the CoA of the TCA cycle [182]. 
In E.coli and S. Typhimurium, the de novo synthesis of pantothenate molecule relies on their 
ketopantoate reductase genes [246]. In contrast, F. tularensis virulent Schu S4 strain lacks 
these genes, but still synthesizes the pantothenate molecule [182]. F. tularensis LVS, on the 
other hand, harbors the ketopantoate reductase genes and loss of any of these genes renders the 
bacteria auxotrophic for pantothenate [182]. The ketopantoate reductase genes in F. tularensis 
are composed of a group of five genes (coaX, panD, panC, panB, and panG) that promote the 
enzymatic reaction of pantothenate synthesis. F. novicida requires the coaX gene for the 
successful dissemination into mice organs [247].  Moreover, a striking increase in the 
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expression level of F. tularensis ketopantoate reductase genes post-invasion of bone marrow-
derived macrophages has been reported [160].  Similarly, lack of both PanC and PanD in 
attenuates the virulence of M. tuberculosis in mice [248]. These studies established the 
significance of pantothenate for F. tularensis in vivo and in vitro intracellular life cycles. Our 
analysis indicated that all of the five ketopantoate reductase genes were significantly 
downregulated after exposing the ΔaraC mutant to menadione. Therefore, we infer from these 
observations that during oxidative stress, F. tularensis employs the AraC transcriptional 
regulator to synthesize the pantothenate that consequently contributes to the formation of CoA 
enzyme. The acetylation of CoA enzyme then initiates the TCA cycle. 
  Our observations further indicate that AraC is also involved in the positive regulation of 
glucose metabolism in F. tularensis LVS. Three genes pgk, pyk, and fba were significantly 
downregulated in the ΔaraC mutant after menadione treatment. PGK (phosphoglycerate 
kinase) is an essential enzyme for the breakdown of glucose into pyruvate and subsequently, 
the release of high energy [185]. Correlation between phosphoglycerate kinase and bacterial 
virulence has not been completely established. However, it has been reported that PGK is 
required for Corynebacterium glutamicum (C. glutamicum) growth as bacteria with the pgk 
gene deletion is deficient for glucose metabolism [249]. Furthermore, deletion of the pyruvate 
kinase encoding gene (pyk) in C. glutamicum resulted in a growth defect even in the culture 
media supplemented with glucose [250]. In contrast, in this study, it was observed that both 
the pgk and pyk genes were downregulated in the ΔaraC mutant but the growth rate of the 
ΔaraC mutant remained similar to the wild type F. tularensis LVS when grown in CDM 
supplemented with D-glucose (Figure 14C). In Enterococcus faecalis, PYK activation is 
promoted by fructose 1,6-bisphosphate (FBP) [186], which is then metabolized by the enzyme 
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fructose-bisphosphate aldolase class II (FBA). The FBA is indispensable for the viability 
during acute and chronic stages of several bacterial pathogens including M. tuberculosis [251]. 
Several efforts to disrupting the fba gene in E. coli, B. subtilis, and P. aeruginosa have failed 
[187]. Moreover, in addition to the bacterial pathogens, Toxoplasma gondii, an intracellular 
parasite, requires the fba gene for survival, multiplication, and pathogenesis [252]. A study has 
shown that the FBA plays an important role in Francisella cytosolic replication only if 
gluconeogenesis substrate is available but is not required required for the bacterial escape from 
the phagosome [187]. Additionally, deletion of fba gene in Francisella induces the expression 
of the antioxidant enzyme KatG [187]. Since OxyR regulates the expression of katG [156], it 
has been proposed that fba serves as a secondary regulator for katG [187]. In the present study, 
the expression of katG gene was not affected by araC deletion. Therefore, we suggest that 
AraC positively regulates the gluconeogenesis and glycolysis pathways in F. tularensis to 
enhance the cytosolic replication. Further, as the end product of glucose metabolism is 
pyruvate, which is a key molecule in initiating the TCA cycle, AraC may contribute to the 
regulation of the TCA cycle indirectly through the carbon metabolism. 
  We have also noted the involvement of AraC in the positive regulation of tpiA gene 
encoding triosephosphate isomerase, an enzyme required for glucose metabolism and TCA 
cycle. Bacterial glycolytic enzymes are different than those of the eukaryotes in their 
involvement in pathogenesis [253, 254]. In Staphylococcus aureus, Lactobacillus plantarum, 
and Paracoccidioides brasiliensis, TPI is essential for attachment to host cells in addition to 
its function in glycolysis [156]. In M. tuberculosis, tpi is required for intracellular growth 
[255]. Deletion of tpi in M. tuberculosis attenuates the bacterial virulence in vivo [255]. 
Conversely, TPI in other bacteria, including E. coli and S. Typhimurium, is involved in, but 
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not required for pathogenesis [256]. Consistent with these observations, it appears that AraC-
mediated regulation of TPI may contribute to the virulence of F. tularensis.  
  The RNA-seq data analysis also demonstrated the downregulation of an additional gene 
(glmM) in menadione treated ΔaraC mutant that is involved in glucose metabolism. The glmM 
gene encodes for phosphoglucosamine mutase enzyme that catalyzes the conversion of 
glucosamine-6-phosphate into glucosamine-1-phosphate in the cytosol [257]. The end product 
of this reaction is essential for the synthesis of bacterial peptidoglycan [258]. In addition, 
GlmM enzyme is essential for virulence of Gram-positive bacteria. However, several reports 
demonstrated that the GlmM enzyme is required for the survival of most Gram-negative 
bacteria including E. coli, S. Typhimurium, P. aeruginosa, and H. pylori [259-261]. Similarly, 
the downregulation of glmM in the ΔaraC mutant during oxidative stress further explains the 
attenuation of virulence of the ΔaraC mutant. Furthermore, the defect in glucose metabolism 
due to the downregulation of GlmM can also cause a subsequent shortening of the TCA cycle 
and reduce bacterial fitness in response to oxidative stress. Energy production impeded by the 
glucose metabolism defect thus may cause the ΔaraC mutant to become less viable 
intracellularly than the wild type F. tularensis LVS. Although not investigated in this study, 
the downregulation the glmM may also result in a defect in the ΔaraC mutant peptidoglycan 
layer and thus may affect the bacterial integrity and permeability and increase susceptibility to 
oxidants.  
  The results from the whole transcriptome analysis of the ΔaraC mutant also revealed the 
downregulation of adenine phosphoribosyltransferase encoding gene (apt) after treatment with 
menadione. The adenine phosphoribosyltransferase catalyzes the conversion of free adenine 
into AMP [262], which can further be utilized for the interconversion into ADP and/or ATP. 
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AMP also contributes to the synthesis of the acetyl-CoA, the central enzyme in the TCA cycle 
[263]. Furthermore, AMP is a key constituent of the RNA [263]. Additional genes that were 
downregulated within the same metabolic operon included secG, encoding the SecG translocon 
subunit, as well as Succinate dehydrogenase encoding genes (sdhA, sdhB, sdhC, sdhD). 
Collectively, these results indicate that AraC may play an essential role in F. tularensis 
pathogenesis by positively regulating the AMP synthesis thereby promoting the TCA cycle. 
  The results from this study further informed that AraC of F. tularensis also controls the 
expression of antiporters and regulatory proteins. One of these genes encodes an amino acid 
antiporter. This antiporter is an arginine (ArgP) transporter. Attenuation of ArgP results in a 
delayed phagosomal escape and defect in cytosolic replication [264]. A study has established 
that this arginine transporter in F. novicida and F. tularensis LVS support metabolic pathways 
during intracellular invasion [264, 265], highlighting the significance of arginine for 
Francisella pathogenesis. Furthermore, it was also determined that deficiency in arginine 
acquisition caused a defect in the production of ribosomal proteins [264].  Suppression of the 
synthesis of ribosomal proteins is commonly observed in organisms exposed to various stress 
conditions [264]. Therefore, arginine plays a crucial role in promoting the phagosomal escape 
and enhancing intracellular replication. In agreement with the literature, exposing ΔaraC 
mutant to oxidative stress resulted in the downregulation of argP, thus, may limit the arginine 
acquisition and defective protein synthesis ultimately resulting in attenuation of 
intramacrophage growth.  
     The results from this study additionally revealed that AraC positively regulates the 
expression of other regulatory genes, rpoB, and rpoC. These genes encode two key 
components, the β (RpoB) and β’ (RpoC) that constitutes the catalytic core of RNA polymerase 
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[266]. RpoB and RpoC were both downregulated in the ΔaraC mutant after menadione 
treatment, indicating inhibition of protein synthesis, thus reducing the viability intracellularly 
than the wild type bacteria. The downregulation of the rpoB and rpoC in conjunction with 
downregulation of argP further indicate the suppression of protein synthesis in the ΔaraC 
mutant. Furthermore, the NAD(P)/FAD-dependent oxidoreductase encoding gene was 
upregulated in the ΔaraC mutant in response to oxidative stress. This enzyme catalyzes the 
redox reactions NAD(P)H or NAD(P)+. The induction of NAD(P)H or NAD(P)+ indicates a 
defect in the electron transport chain homeostasis, which subsequently reduces the bacterial 
viability.  
  In addition to the role of AraC in regulating operons, the results from whole 
transcriptome analysis revealed the involvement of AraC in regulating genes transcribed as 
single transcriptional units. Data analysis demonstrated that type I DNA topoisomerase was 
downregulated in the ΔaraC mutant when treated by menadione. Inhibition of topoisomerase 
I had been exploited as a target for therapeutics in several organisms including E. coli, Y. pestis, 
and Streptococcus pneumoniae [267, 268], indicating its importance in pathogenesis. F. 
tularensis requires the activity of topoisomerase I to repair DNA damages and supercoils 
exerted by exposing to the oxidative agents. Our results demonstrate that AraC negatively 
regulates Topoisomerase I when F. tularensis is exposed to oxidative stress. 
  Furthermore, the data analysis indicated that AraC of F. tularensis also negatively 
regulates pyrH gene that encodes the uridylate (UMP) kinase enzyme. E. coli utilizes the UMP 
kinase to establish de novo pyrimidine nucleotides synthesis [269], providing evidence of the 
importance of the pyrH gene. Similarly, F. tularensis employ the UMP kinase to compensate 
for nucleotides damage as a result of oxidative stress.  
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  Lastly, the results from this study revealed the involvement of AraC in the negative 
regulation of two genes of F. tularensis. One of these genes encodes serine/threonine 
transporter. These results indicate that along with arginine transporter, additional amino acid 
transporters such as serine/threonine transporter are also under the control of AraC. Legionella 
pneumophila harbors MFS threonine transporter, which contributes to the intracellular 
bacterial replication [270]. Both Francisella and Legionella mostly rely on amino acids as the 
main carbon [271]. It was observed that exposing ΔaraC mutant to oxidative stress 
significantly upregulated serine/threonine transporter gene indicating that in response to 
oxidative stress, AraC of F. tularensis restricts the amino acid uptake and relies on arginine to 
conserve energy. Moreover, the induction of the serine/threonine transporter in ΔaraC mutant 
also indicates that mutant is hunting for every nutritional source to maintain its viability.  
  The other gene that is negatively regulated by AraC in regards to oxidative stress is the 
one encoding acid phosphatase. Acid phosphatase is an enzyme that catalyzes inorganic 
phosphates mobility [272]. It is also engaged in the eukaryotic and prokaryotic phosphor-relay 
system [272]. Acid phosphatase is required by Francisella strains for intramacrophage growth 
[273, 274]. However, the virulent strains (type A and B) strains do not employ acid 
phosphatases to overcome intracellular oxidative burst [274]. F. tularensis virulent strains rely 
on fevR to overcome NADPH oxidase [274]. There are at least five acid phosphatases identified 
in Francisella [272], which are encoded by distinct genes than the one induced in our analysis. 
The gene encoding acid phosphatase was significantly upregulated in ΔaraC mutant after 




  Collectively, the results obtained from the present study demonstrate that AraC 
transcriptional regulator exerts a global regulatory role on several key pathways of F. 
tularensis LVS. We determined that AraC regulates FPI genes and contributes to the in vivo 
and in vitro virulence of the F. tularensis LVS strain. We also unraveled the regulatory role of 
the AraC in heat shock proteins in response to oxidants and heat stress. Additionally, AraC 
plays an important role in regulating F. tularensis LVS metabolic pathways, specifically the 
TCA cycle, by targeting key enzymes that are indispensable for the cycle. We further observed 
the engagement of the AraC in the regulation of DNA repair pathways as well as controlling 
protein synthesis of F. tularensis during oxidative stress. Altogether, we conclude that AraC 
belonging to the AraC/XylS family of transcription regulator plays an essential role in 
oxidative stress response of F. tularensis LVS.  
Significance of the study and future directions 
  This study provides a wide range of knowledge about F. tularensis LVS response to 
oxidative stress from the point view of gene regulation. It provides a powerful tool for 
tularemia therapeutic applications. Up until now, efforts have been focused on developing 
effective tularemia treatment with little success. The present study characterized a global 
transcription regulator that controls several pathways in F. tularensis LVS and thus, can be 
utilized as an effective target to develop effective tularemia therapeutics.  
  In the future, we aim to determine the exact mechanism of AraC-dependent regulation 
of these virulence and metabolic pathways by identifying binding domains in the promoter 
regions of the regulated genes/operons by chromatin immunoprecipitation (ChIP) sequencing 
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